EurekaMag PDF full texts Chapter 35,433

Ehlich, R.; Altebaeumer, T.; Kern, D.P.; Raschke, M.; Nibbering, E.T.J.; Lienau, C.; Hoerber, J.K.H.inrich 2004: Optical stimulated biochemical synthesis on metal/semiconductor-nanostructures. Biophysical Journal 86(1): 160a

Reber, W.L.; Perttunen, C.D. 2000: Optical storage medium for binding assays. Official Gazette of the United States Patent and Trademark Office Patents 1237(5)

Hill, Henry Allen 2003: Optical storage system based on scanning interferometric near-field confocal microscopy. Official Gazette of the United States Patent and Trademark Office Patents 1273(2)

Houge, Erik Cho 2003: Optical structures and methods for x-ray applications. Official Gazette of the United States Patent and Trademark Office Patents 1274(4)

Svoboda, K. 1999: Optical studies of single synapses in brain slices. Biophysical Journal 76(1 Part 2): A142

Sato, K.; Nakazawa, K.I.; Matsuki, N.; Ohno, Y. 1999: Optical studies of the effects of ATP on the excitatory propagation in organotypic hippocampal culture. Japanese Journal of Pharmacology 79(Suppl 1): 232P

Gulli, Christian; Leger, Alain; Bignolles, Laurent; Lamarque, Frederic; Le Gargasson, Jean FranCedillaOis 2000: Optical system combining image presentation and eye analysis. Official Gazette of the United States Patent and Trademark Office Patents 1241(2)

Maki, A.; Koizumi, H.; Kawaguchi, F.; Yamashita, Y.; Ito, Y. 2001: Optical system for measuring metabolism in a body and imaging method. Official Gazette of the United States Patent and Trademark Office Patents 1249(4)

Utsui, T. 2002: Optical system for the light source device of a video endoscope system. Official Gazette of the United States Patent and Trademark Office Patents 1264(3)

Pinkhasik, N.; Sorin, L.E. 2003: Optical system of lateral observation endoscope. Official Gazette of the United States Patent and Trademark Office Patents 1268(4)

Mcfarland, E.W.; Danielson, E.; Archibald, W. 2002: Optical systems and methods for rapid screening of libraries of different materials. Official Gazette of the United States Patent and Trademark Office Patents 1261(4)

Geisler, J.P.; Geisler, H.E.; Wiemann, M.C.; Zhou, Z.; Miller, G.A.; Crabtree, W. 1999: Optical texture parameters as prognostic indicators in ovarian carcinoma. Gynecologic Oncology 72(3): 493

Gonzalez, J.M.; Saiz-Jimenez, C. 2003: Optical thermal cycler for use as a fluorimetric plate reader to estimate DNA concentrations. Biotechniques 34(4): 710-712

Dubois, B.R. 1999: Optical tissue dissector/retractor. Official Gazette of the United States Patent and Trademark Office Patents 1222(2)

Toida, M. 2003: Optical tomography imaging method and apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1274(5)

Tyson, F.C.; Pandey, S.K.; Apple, D.J.; Mcintyre, D.; Peng, Q. 1999: Optical topography A new method of IOL optical property analysis. IOVS Investigative Ophthalmology and Visual Science 40(4): S298

Ogawa, H.; Shimizu, R.; Kaneko, H.; Oka, K. 1999: Optical tracing of the neural activities evoked by mechanical or light stimulation in the earthworm ventral nerve cord with a fluorescence dye, FM1-43. Zoological Science 16(Suppl ): 120

Lai, M. 2002: Optical tracking based on a change in optical reflection across a reference mark on an object to be tracked. Official Gazette of the United States Patent and Trademark Office Patents 1257(2)

Lai, M. 2001: Optical tracking device. Official Gazette of the United States Patent and Trademark Office Patents 1242(5)

Von Albertini, B.; Berger, J.; Pereira, O.; Bringolf, M.; Wauters, J.P.; Haynie, M. 2001: Optical transdermal vascular access blood flow measurements in patients off hemodialysis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 306A

Schalkhammer, T.; Stich, N.; Bauer, G.; Palkovits, R.; Pittner, F. 2000: Optical transduction of structural changes of proteins using surface enhanced nano cluster resonance. Cytometry Suppl (10): 51

Kuyper, C.L.; Chiu, D.T. 2002: Optical trapping A versatile technique for biomanipulation. Applied Spectroscopy 56(11): 300A-312A

Greulich, Karl Otto 1999: Optical trapping and manipulation. Koehler, J M, Mejevaia, T, Saluz, H P Biomethods; Microsystem technology: A powerful tool for biomolecular studies 453-474

Collins, M.J.; Wildsoet, C.F. 2000: Optical treatment method. Official Gazette of the United States Patent and Trademark Office Patents 1233(1)

Sauer, J.S.; Oravecz, M.G.; Greenwald, R.J.; Kobilansky, A.I. 2004: Optical trocar. Official Gazette of the United States Patent and Trademark Office Patents 1279(1)

Frick, M.; Singer, W.; Bernet, S.; Haller, T.; Mair, N.; Ritsch Marte, M.; Dietl, P. 2001: Optical tweezers A new approach to study surfactant-secretion in alveolar type II cells. Pfluegers Archiv European Journal of Physiology 441(6 Suppl): R178

Brown, B.A.; Brown, P.R. 2001: Optical tweezers Theory and current applications. American Laboratory 33(22): 13-20

Mccord, R.P.; Bernd, K.K.; Yukich, J.N. 2004: Optical tweezers and biological forces Using a laser trap to measure the swimming force exerted by the flagella of Chlamydomonas reinhardtii. Biophysical Journal 86(1): 225a

Coirault, C.; Pourny, J-Claude.; Lambert, F.; Lecarpentier, Y. 2003: Optical tweezers in biology and medicine. Medecine Sciences: M/S 19(3): 364-367

Berg Sorensen, K.; Oddershede, L.B.; Grego, S.; Dreyer, J.K.; Norrelykke, S.F.; Brown, S. 2000: Optical tweezers study of diffusion of proteins in membranes. European Biophysics Journal 29(4-5): 302

Okumura, A.; Nakada, K. 2002: Optical water-absorptive gel and ophthalmic material using the same. Official Gazette of the United States Patent and Trademark Office Patents 1262(2)

Gripp, S.; Haesing, F. 2001: Optical wave guides in radiation dosimetry. European Journal of Cancer 37(Suppl 6): S213

Lessar, J.F.; Miesel, K.A.; Tettemer, S.A.; Olson, J.C. 1999: Optical window for implantable medical devices. Official Gazette of the United States Patent and Trademark Office Patents 1222(2)

Moros Garcia, M.; Martinez Tello, D.; Mena Gutierrez, M.V. 1999: Optical, ultrastructural and immunohistochemical profile of adenomyoepithelioma of the breast. Virchows Archiv 435(3): 203

Brown, J.A.; Bernie, J.E.; Sundaram, C.P. 2004: Optical-access visual obturator trocar entry into the desufflated abdomen during laparoscopy An assessment after 96 cases. Journal of Urology 171(4 Suppl): 335

Vardi, G.M.; Spivak, V.; Spivak, E. 2003: Optical-acoustic imaging device. Official Gazette of the United States Patent and Trademark Office Patents 1277(2)

Colvin, A.E.Jr; Dale, G.A.; Zerwekh, P.S.; Lesho, J.C.; Lynn, R.W. 2001: Optical-based sensing devices. Official Gazette of the United States Patent and Trademark Office Patents 1253(2)

Colvin, Arthur, E.Jr 2001: Optical-based sensing devices, especially for in-situ sensing in humans. Official Gazette of the United States Patent and Trademark Office Patents 1251(3)

Hashimoto, T. 2000: Optical-recorded auditory cortical activity of guinea pig. Neuroscience Research Suppl (24): S157

Thomasson, J.A.; Sui, R. 2004: Optical-reflectance-based mass-flow sensor. Official Gazette of the United States Patent and Trademark Office Patents 1287(4)

Nishino, M.; Tanaka, H.; Shimazu, T.; Sugimoto, H. 1999: Optically accessible microchannels revealed that LPS and IL-1beta decrease neutrophil deformability in anesthetized rats. FASEB Journal 13(4 Part 1): A89

Kawamura, K.; Ueno, M.; Suzuki, M.; Yanai, M.; Takahashi, T.; Itoh, K. 2001: Optically active 1,4-benzodioxin-2-carboxylic acid derivatives and process for producing the same. Official Gazette of the United States Patent and Trademark Office Patents 1253(2)

Ikeda, T.; Kawamura, M.; Ge, Y.T.ng 2000: Optically active 1,4-dihydropyridine compounds as bradykinin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1241(1)

Lévai, A. 1999: Optically active 1,5-benzothiazepines. Die Pharmazie 54(10): 719-726

Ito, M.; Yamasaki, N.; Kobayashi, Y.; Ikura, K. 1999: Optically active 1-phenyl-2-substituted propane derivatives and methods of producing the same. Official Gazette of the United States Patent and Trademark Office Patents 1222(2)

Chern, J.W.; Gutcait, A.; Liu, H.W.; Wang, K.C. 1999: Optically active 2,3-dihydroimidazo quinazoline derivatives, the preparation and antihypertensive use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1225(1)

Moretti, G.P.; Foresta, P. 2001: Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock. Official Gazette of the United States Patent and Trademark Office Patents 1246(1)

Sohda, T.; Taketomi, S.; Oda, T. 2002: Optically active 2R, 4S benzothiepin isomer. Official Gazette of the United States Patent and Trademark Office Patents 1255(2)

Kudo, J.; Hirata, N.; Yoshida, T. 2004: Optically active 4- piperazine compound, and method for producing the same. Official Gazette of the United States Patent and Trademark Office Patents 1287(2)

Cotrel, C.; Roussel, G. 2001: Optically active 5H-pyrrolo pyrazine derivative, its preparation and pharmaceutical compositions containing it. Official Gazette of the United States Patent and Trademark Office Patents 1252(3)

Horie, R.; Ishiguro, T. 2001: Optically active DNA probe having phosphonic diester linkage. Official Gazette of the United States Patent and Trademark Office Patents 1245(1)

Kobayashi, S.; Ishitani, H. 2002: Optically active alpha-aminonitrile and process for producing alpha-amino acid. Official Gazette of the United States Patent and Trademark Office Patents 1254(3)

Sato, H.; Ohno, T.; Iwata, S. 2004: Optically active amino acid derivatives and processes for the preparation of the same. Official Gazette of the United States Patent and Trademark Office Patents 1280(3)

Knoll, J.; Yoneda, F.; Ohde, H.; Sakae, M.; Moto, T.; Ando, T.; Shimazu, S.; Takahata, K. 2002: Optically active aminopentane derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1258(3)

Yoshioka, R.; Yamada, S.I.; Shibatani, T. 1999: Optically active benzothiazepine compounds and process for preparing the same. Official Gazette of the United States Patent and Trademark Office Patents 1224(4)

Park, S.; Kwon, H.; Kim, H.; Ho, P.; Morikawa, K.; Kanbe, Y.; Nishimoto, M.; Kim, M. 2003: Optically active chroman and thiochroman derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1273(4)

Zhang, J.; Huang, L.; Wu, K.; Chen, S. 2004: Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use. Official Gazette of the United States Patent and Trademark Office Patents 1286(1)

Sudhakar, A.R.; Tang, S. 2001: Optically active intermediates for the preparation of optically active substituted oximes, hydrazones and olefins useful as neurokinin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1248(4)

Shibasaki, M.; Sasai, H.; Urata, Y.; Fujita, M. 2003: Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same. Official Gazette of the United States Patent and Trademark Office Patents 1275(2)

Nobbs, M.S.; Rodgers, S.J. 2000: Optically active phenyl pyrimidine derivatives as analgesic agent. Official Gazette of the United States Patent and Trademark Office Patents 1238(4)

Rmaile, H.H.; Schlenoff, J.B. 2003: Optically active polyelectrolyte multilayers as membranes for chiral separations. Journal of the American Chemical Society 125(22): 6602-6603

Hayakawa, I.; Kimura, Y. 2000: Optically active pyridonecarboxylic acid derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1231(5)

Jednakovits, A.; Urogdi, L.; Denes, L.; Kurucz, I.; Marvanyos, E.; Barabas, M.; Bacsy, E.; Korom, Z.; Nagy, Z.; Urge, L.; Szilbereky, J.; Acsai, K.; Krajcsi, P.; Csakai, Z.; Torok, M. 2002: Optically active pyridyl-4h-1,2,4-oxdadiazine derivative and its use in the treatment of vascular diseases. Official Gazette of the United States Patent and Trademark Office Patents 1258(1)

Hagihara, M.; Shibakawa, N.; Matsunobu, K.; Fujiwara, H.; Ito, K. 2003: Optically active pyrrolopyridazine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1277(5)

Yoon, S.J.; Chung, Y.H.; Lee, C.W.; Lee, J.S.; Kim, N.D.; Jin, Y.H.; Song, W.J.; Kim, I.H.; Yang, W.Y.; Choi, D.R.; Shin, J.H. 2003: Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof. Official Gazette of the United States Patent and Trademark Office Patents 1276(3)

Nakazato, A.; Kumagai, T.; Miyazawa, T.; Ohta, K.; Kawashima, Y.; Hatayama, K. 1999: Optically active substituted phenylalkylamine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1228(4)

Ishihara, S.; Saito, F.; Ohhata, Y.; Miyake, S.; Yorikane, R.; Fukuda, N. 1999: Optically active thiazolidinone derivative. Official Gazette of the United States Patent and Trademark Office Patents 1224(3)

Hanazawa, T.; Koiwa, M.; Hareau, G.P.J.; Sato, F. 2000: Optically active trans-4- -5- -2-cyclohexenone as a useful chiral building block for preparation of substituted cyclohexane rings Synthesis and its highly stereoselective reaction with RCu Li. Tetrahedron Letters 41(15): 2659-2662

Austin, R.H.; Tegenfeldt, J.O.; Chan, E.Y. 2004: Optically characterizing polymers. Official Gazette of the United States Patent and Trademark Office Patents 1286(2)

Halloran, Daniel Joseph 2000: Optically clear hair conditioning compositions containing aminofunctional silicone microemulsions. Official Gazette of the United States Patent and Trademark Office Patents 1240(2)

Christ, R.; Nash, B.A.; Petraitis, D.J. 2001: Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses. Official Gazette of the United States Patent and Trademark Office Patents 1249(3)

Halloran, Daniel Joseph 2000: Optically clear shampoo compositions containing aminofunctional silicone microemulsions. Official Gazette of the United States Patent and Trademark Office Patents 1240(4)

Nisch, W.; Stelzle, M.; Weiss, S.; Zrenner, E.; Gunther, E.; Stett, A.; Graf, H.G.; Graf, M.; Schubert, M.B.; Wanka, H.N.; Hierzenberger, A. 2002: Optically controllable microelectrode array for stimulating cells within a tissue. Official Gazette of the United States Patent and Trademark Office Patents 1255(2)

Cosman, E.R. 2002: Optically coupled frameless stereotactic space probe. Official Gazette of the United States Patent and Trademark Office Patents 1255(4)

Tominaga, T.; Tominaga, Y.; Ichikawa, M. 2000: Optically detected long-lasting depolarization of the post-synaptic dendrite membrane upon high frequency and theta burst stimulus in rat hippocampus CA1 region. Neuroscience Research Suppl (24): S96

Kojima, S.; Ito, E. 1999: Optically detected slow depolarizing response in the median lip nerve of the pond snail, Lymnaea stagnalis. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 124(Suppl ): S144

Dinsmore, M. 2002: Optically driven therapeutic radiation source. Official Gazette of the United States Patent and Trademark Office Patents 1264(2)

Dinsmore, M. 2002: Optically driven therapeutic radiation source having a spiral-shaped thermionic cathode. Official Gazette of the United States Patent and Trademark Office Patents 1265(2)

Dinsmore, M. 2004: Optically driven therapeutic radiation source including a non-planar target configuration. Official Gazette of the United States Patent and Trademark Office Patents 1281(2)

Dinsmore, M. 2003: Optically driven therapeutic radiation source with voltage gradient control. Official Gazette of the United States Patent and Trademark Office Patents 1277(1)

Cunin, F.; Link, J.R.; Schmedake, T.A.; Li, Y.Y.; Bhatia, S.; Koh, J.; Sailor, M.J. 2002: Optically encoded photonic crystals of porous silicon for biomolecular screening applications. Abstracts of Papers American Chemical Society 224(1-2): COLL 171

Visuri, Steven R.; Campbell, Heather L.; Da Silva, Luiz 2002: Optically generated ultrasound for enhanced drug delivery. Official Gazette of the United States Patent and Trademark Office Patents 1264(3)

Innocenti, B.; Haydon, P.G. 1999: Optically monitored glutamate release during astrocytic calcium waves. Society for Neuroscience Abstracts 25(1-2): 1505

Young, J.W. 2002: Optically pure amlodipine compositions. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)

Gant, Thomas George 2000: Optically pure androgen mediator. Official Gazette of the United States Patent and Trademark Office Patents 1236(1)

Patel, H.I.; Daffern, G.M. 2002: Optically readable strip for analyte detection having on-strip orientation index. Official Gazette of the United States Patent and Trademark Office Patents 1254(1)

Hataya, R.; Shirai, M. 2003: Optically stimulated luminescence dating of shallow marine sediments. Quaternary Research 42(5): 347-359

Navis, J.A. 1999: Optically transparent medical instrument cover. Official Gazette of the United States Patent and Trademark Office Patents 1229(2)

West, J.L.; Drezek, R.; Sershen, S.; Halas, N.J. 2004: Optically-absorbing nanoparticles for enhanced tissue repair. Official Gazette of the United States Patent and Trademark Office Patents 1279(1)

West, J.L.; Halas, N.J.; Hirsch, L.R. 2003: Optically-active nanoparticles for use in therapeutic and diagnostic methods. Official Gazette of the United States Patent and Trademark Office Patents 1268(2)

Kojima, S.; Ito, E. 1999: Optically-detected Ca2+ signaling in glial cells of the lip nerve of the pond snail, Lymnaea stagnalis. Zoological Science 16(Suppl ): 95

Kanerva, L.; Estlander, T.; Jolanki, R. 2001: Optician's occupational allergic contact dermatitis, paresthesia and paronychia caused by anaerobic acrylic sealants. Contact Dermatitis 44(2): 117-119

Eikelenboom, M.J.; Killestein, J.; Uitdehaag, B.M.; Polman, C.H. 2004: Opticospinal multiple sclerosis: a pathogenetically distinct form?. Multiple Sclerosis 10(3): 334-335

Douglas, J.S.; Roe, J.N.; Priest, J.H.; Gleisner, J.M.; Raney, C.C.; Hasker, D.A.; Radwanski, R.; Ramirez, J. 2004: Optics alignment and calibration system. Official Gazette of the United States Patent and Trademark Office Patents 1283(3)

Laurita, K.R.; Libbus, I. 2001: Optics and detectors used in optical mapping. Rosenbaum, David S, Jalife, Jose Optical mapping of cardiac excitation and arrhythmias 61-78

Ofri, R. 1999: Optics and physiology of vision. Gelatt, K N Veterinary ophthalmology, Third edition 183-216

Eshbaugh, C.G.; Polchak, J.R.; Krueger, R.R. 2000: Optics of refractive surgery. International Ophthalmology Clinics 40(3): 1-10

Egri, A.ám.; Horváth, A.; Kriska, G.ör.; Horváth, G.áb. 2010: Optics of sunlit water drops on leaves: conditions under which sunburn is possible. New Phytologist 185(4): 979-987

Van, D.B.rg, T.J.; Hagenouw, M.P.; Coppens, J.E. 2001: Optics of the ciliary corona. IOVS Investigative Ophthalmology and Visual Science 42(4): S162

Chalam, K.V.; Shah, V.A. 2004: Optics of wide-angle panoramic viewing system-assisted vitreous surgery. Survey of Ophthalmology 49(4): 437-445

Sezer, O.; Possinger, K.; Metzner, B.; Illiger, H.J.; Wattad, M.; Heit, W.; Fuss, H.; Schultze, W. 2000: Optimal CD34(+) cell dose in autologous peripheral-blood stem-cell transplantation. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18(18): 3319-3320

Jelley Gibbs, D.M.; Lepak, N.; Swain, S.L. 2000: Optimal CD4 T cell proliferation and function requires a brief T cell receptor stimulus followed by an antigen-independent, IL-2 driven phase of cell expansion. FASEB Journal 14(6): A1167

Thumann, P.; Jenne, L.; Urlacher, J.; Schuler, G.; Berger, T.G. 2003: Optimal DC migration is depending on the duration of maturation. Journal of Investigative Dermatology 121(5): 1241

Vink, Roel; Kraaijenhagen, Roderik A.; Hutten, Barbara A.; Brink, Renee B.A. Van Den; De Mol, Bas A.; Levi, Marcel 2002: Optimal Intensity of Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves. Blood 100(11): Abstract No. 2768

Cheng, W.; Lohman, T.M. 2000: Optimal activity of E coli Rep DNA helicase requires protein oligomerization. Biophysical Journal 78(1 Part 2): 302A

Bathori, G.; Rethy, L.A.; Kontrohr, T.; Rethy, L. 2000: Optimal adjuvation A cardinal principle during application of liposome-adjuvants. Immunology Letters 73(2-3): 212

Croft, P.; Chambers, D.J. 1999: Optimal administration of a novel analogue of phosphoenolpyruvate for improved ischemic protection. Journal of Molecular and Cellular Cardiology 31(6): A124

Kokudo, S.; Nishijima, T.; Suzuki, K.; Ozawa, H.; Ohsawa, S.; Matsuda, H.; Noda, Y.; Yagi, N.; Kagaya, A.; Naito, H.; Aoki, J.; Kobayashi, K. 2003: Optimal age of swimming and gymnastic skill development on Japanese children and youths. Medicine and Science in Sports and Exercise 35(5 Suppl): S22

Witkowski, S.; Karlsen, T.; Resaland, G.; Sivieri, M.; Yates, R.; Harber, M.; Ge, R.L.; Stray Gundersen, J.; Levine, B.D. 2001: Optimal altitude for living high-training low. Medicine and Science in Sports and Exercise 33(5 Suppl): S292

Suma, S.; Krishnaiengar, S.R.; Hegde, J.; Basavaraju, N.C.; Rama, D.V.; Srilakshmi, M.A.; Joshi, S.; Vinaya, A.S.; Narayan, G.S.; Dayashankar, U.; Sudha, B.S.; Mamatha, A.H.; Raja, G.; Kalpana, T.; Sumithra, N.; Ishrath, N 2000: Optimal and maximal eulipidemic therapy in diabetes Tailored drug combinations and estrogen replacement. Diabetes Research and Clinical Practice 50(Suppl 1): S316

Girardi, M.; Tigelaar, R.E.; Filler, R.; Hayday, A.C. 2000: Optimal anti-tumor immunity to murine squamous cell carcinoma is dependent on both CD4+ and CD8+ T cell responses. Journal of Investigative Dermatology 114(4): 801

Haaijer Ruskamp, F.M. 2003: Optimal antibiotic prescribing Who should be educated. Tulunay, F C , Orme, M European collaboration: Towards drug development and rational drug therapy : 17

Madan, M.; Radhakrishnan, S.; Pang, J.T.; Della Siega, A.J.; Reis, M.; Paradiso Hardy, F.L.; Godin Edgecombe, M.; Shanmugasegaram, S.; Fort, S.; Naqvi, S.Z.; Cohen, E.A. 2001: Optimal anticoagulation and platelet inhibition are achieved when enoxaparin is combined with small molecule glycoprotein IIb/IIIa inhibition during elective percutaneous coronary intervention. Circulation 104(17): 2; 385

Ten Berg, J.M.; Hutten, B.A.; Kelder, J.C.; Verheugt, F.W.A.; Plokker, H.W.T.ijs 2000: Optimal anticoagulation with coumadin during and after coronary angioplasty improves clinical outcome. European Heart Journal 21(Abstract Suppl): 381

Henriksen, T.H.; Lia, A.; Thoresen, T.; Schoyen, R. 1999: Optimal atmosphere for growth of Helicobacter pylori. Gut 45(Suppl 3): A14

Kedar, D.M.; Slaton, J.W.; Dinney, C.P.N.; Killion, J.J.; Fidler, I.J. 2001: Optimal biological dose of pegilated interferon-alpha inhibits angiogenesis and growth of human transitional cell carcinoma in the bladder of nude mice. Proceedings of the American Association for Cancer Research Annual Meeting 42: 568

King, C.R.; Mayo, C.S. 2000: Optimal brachytherapy for prostate cancer LDR versus HDR The view from radiobiologic models, or you take the high road and Ill take the low road. Cancer Journal 6(2): 98

King, C.R.; Mayo, C.S. 2001: Optimal brachytherapy for prostate cancer LDR versus HDR The view from radiobiological models, or you take the high road and Ill take the low road. International Journal of Radiation Oncology Biology Physics 51(3 Suppl 1): 311-312

King, C.R.; Mayo, C.S. 2001: Optimal brachytherapy for prostate cancer LDR vs HDR The view from radiobiological models, or you take the high road and Ill take the low road. European Journal of Cancer 37(Suppl 6): S219-S220

Sale, K.; Gray, G.; Faulon, J.L.; Schoeniger, J.; Young, M. 2004: Optimal bundling of the transmembrane helices of integral membrane proteins using sparse distance constraints. Biophysical Journal 86(1): 257a

Knell, E.R.; Presant, C.A. 2000: Optimal cancer risk assessment program professional roles; analysis of 30 American centers. Genetics in Medicine 2(1): 68

Casellas, F.; Lopez Vivancos, J.; Badia, X.; Vilaseca, J.; Malagelada, J.R. 1999: Optimal care for patients with inflammatory bowel disease. Gastroenterology 116(4 Part 2): A678

Caney,S. 2010: Optimal care in dealing with feline chronic kidney disease. Veterinary Times: 6, 14-15

Shah, D.; Burri, H.; Sunthorn, H.; Sigwart, U. 2004: Optimal catheter ablation strategy for atrial fibrillation Trigger isolation alone or supplementary left atrial substrate modification?. Journal of the American College of Cardiology 43(5 Suppl A): 5A

Balandin, A.B.; Dimova, A.D. 2004: Optimal choice of antibiotic for local use in patients with external otitis and furuncles in the acoustic meatus. Vestnik Otorinolaringologii 2: 43-45

Barisic, Z.; Babic Erceg, A.; Borzic, E.; Zoranic, V.; Carev, M.; Kaliterna, V. 2002: Optimal choice of antimicrobial therapy for Pseudomonas aeruginosa urinary tract infections in outpatients. International Journal of Antimicrobial Agents 19(Suppl 1): S44-S45

Filburn, T.; Weiss, R.A.; Helble, J.J.; Huang, S.J.; Papale, W. 2002: Optimal choice of immobilized, supported amines for CO2 removal. Abstracts of Papers American Chemical Society 223(1-2): FUEL 74

Capomolla, S.; Febo, O.; Opasich, C.; Riccardi, G.; Caporotondi, A.; Mortara, A.; Cobelli, F. 1999: Optimal chronic intravenous therapy in managing unloading therapy and improving clinical outcome in severe congestive heart failure. European Heart Journal 20(ABSTR Suppl ): 94

Dong, D.W. 2000: Optimal coding The separability of visual sensitivity into spatial frequency and motion velocity based on properties of natural images. IOVS Investigative Ophthalmology and Visual Science 41(4): S796

Fischel, J.L.; Rostagno, P.; Formento, P.; Etienne, M.C.; Milano, G. 1999: Optimal combination between irinotecan , oxaliplatin and flurouracil-folinic acid Experimental data on human colorectal cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 40: 589

Djavan, B.; Remzi, M.; Seitz, C.; Zlotta, A.; Schulman, C.; Marberger, M. 2000: Optimal combination of PSA based parameters to predict the outcome of repeat prostate biopsy. European Urology 37(Suppl 2): 75

Wille, A.; Hoh, J.; Ott, J. 2001: Optimal combination of marker-specific statistics in a two-stage SNP selection method for disease association data. European Journal of Human Genetics 9(Suppl 1): P0838

Soliman, K.; Rybouchkin, A.; Van Der Elst, J.; Dhont, M. 2001: Optimal concentration of FSH and LH for in-vitro maturation of human GV oocytes. Human Reproduction 16(Abstract Book 1): 14

Chung, J.H.; Paek, S.M.; Kim, W.K.; Chong, Y.H. 2000: Optimal concentration of hEGF for epithelial healing in experimental corneal alkali wounds. IOVS Investigative Ophthalmology and Visual Science 41(4): S910

Matsumoto, S.; Fukuda, K.; Tsujitani, S.; Kaibara, N. 2003: Optimal condition for electrofusion of dendritic cells and gastric cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 772

Stieglerova, A.; Chowdhury, S.K.R.; Drahota, Z.; Rauchova, H.; Ost'adal, B.; Houstek, J. 1999: Optimal conditions for determination of maximum cytochrome-c oxidase activity in the rat heart and brain. Physiological Research 48(Suppl 1): S123

Filke, S.; Schilling, A.F.; Rueger, J.M.; Amling, M. 2002: Optimal conditions for generation of active human osteoclasts in vitro Cell source, time, and pH. Journal of Bone and Mineral Research 17(Suppl 1): S347

Yim, J.H.; Kim, S.J.; Ahn, S.H.; Lee, H.K. 2003: Optimal conditions for the production of a sulfated polysaccharide by the marine microalgae Gyrodinium impudicum strain KG03. Biomolecular Engineering 20(2): 71-72

Thomé, R.C.A.; Yang, H.M.; Esteva, L. 2010: Optimal control of Aedes aegypti mosquitoes by the sterile insect technique and insecticide. Mathematical Biosciences 223(1): 12-23

Butkevich, A.; Phillips, R.A. 1999: Optimal control of hypertension and blood pressure variability. Circulation 100(18): 1; 180

Traeger, J.; Galland, R.; Ferrier, M.L.; Delawari, E. 2002: Optimal control of phosphatemia by short daily hemodialysis. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 410A-411A

Keller, H.; Ritter, M.A.; Mackie, T.R. 2001: Optimal correction strategies for reducing systematic and random setup errors and their impact on treatment margins. International Journal of Radiation Oncology Biology Physics 51(3 Suppl 1): 92

El-Hendawy,S.E.; Schmidhalter,U. 2010: Optimal coupling combinations between irrigation frequency and rate for drip-irrigated maize grown on sandy soil. Agricultural Water Management 97(3): 439-448

Dimitriadis, E.K.; Lewis, M.S. 2000: Optimal data analysis using transmitted light intensities in analytical ultracentrifuge. Methods in Enzymology 321: 121-136

Correa-Pérez, J.R.; Fernández-Pelegrina, Ré. 2003: Optimal day for embryo transfer?. Fertility and Sterility 80(4): 1070-1; Author Reply 1071

D.V.ies, A.; Conlin, B.J. 2001: Optimal days in period to detect a change in estrus detection. Journal of Dairy Science 84(Suppl 1): 253

Schillaci, M.E.; Inkret, W.C.; Little, T.H.T.; Martz, H.; Miller, G. 1999: Optimal decision levels-A classical approach to the application of Bayesian statistics. Health Physics 76(6 Suppl): S174

Nakajima, H.; Sakakibara, Y.; Yoshimoto, M.; Premaratne, G.U.; Lin, X.; Kanemitsu, N.; Tambara, K.; Sakaguchi, G.; Nakahata, T.; Komeda, M. 2003: Optimal delivery route and timing in bone marrow cell transplantation should be selected according to the etiology of the heart disease. Circulation 108(17): IV622

Kanamori, T.; Yanagi, K.; Shinbo, T.; Ohshima, N. 2002: Optimal design and treatment prescription of a bioartificial liver system using a mathematical kinetic model. International Journal of Artificial Organs 25(7): 692

Lahana, R. 2003: Optimal design of bioactive peptides. Biopolymers 71(3): 318

Steyermark, A.C.; Diamond, J. 2001: Optimal design of the digestive system. American Zoologist 41(6): 1596

Fisher, C.M.; Woll, M.M.; Peoples, G.E.; Ponniah, S. 2002: Optimal detection of HER2/neu specific CD8 T cells using the HLA-A2lg dimer. Proceedings of the American Association for Cancer Research Annual Meeting 43: 975

Ivanikov, A.A.; Isakov, V.A.; Maev, I.V. 2004: Optimal diagnosis and therapy of gastroesophageal reflux disease. Terapevticheskii Arkhiv 76(2): 71-75

Colyer, W.R.; Burket, M.W.; Cooper, C.J.; Shapiro, J.I.; Thomas, W.J. 2001: Optimal diagnosis of renal ischemia using renal angiography and translesional pressure gradients assessed with a 0014 inch pressure sensing guidewire. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 481A

Peterlin, B.; Hristovski, D.; Kunej, T. 2000: Optimal diagnostic set for Y chromosome deletion screening. European Journal of Human Genetics 8(Suppl 1): 157-158

Buyken, A.E.; Mitchell, P.; Ceriello, A.; Brand-Miller, J. 2010: Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. Diabetologia 53(3): 406-418

Karasov, W.H. 1999: Optimal digestive responses of birds to changing diet and foraging costs. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 124(Suppl ): S63

Hume, I.D.; Faichney, G.J. 1999: Optimal digestive strategies in small mammalian herbivores. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 124(Suppl ): S63

Kennedy, D.J.; Thwaites, D.T. 2002: Optimal dipeptide uptake across the apical membrane of human intestinal Caco-2 cell monolayers is dependent on functional NHE3 activity. Journal of Physiology (Cambridge) 539P: 10P-11P

Roolvink, Vincent; Luijten, Hans E.; Brouwer, Marc A.; Uijen, Gerard J.H.; De Keijzer, Ries; Van Der Werf, Tjeerd; Verheugt, Freek W.A. 2001: Optimal discriminative value of troponin-I for 6 month cardiac event rate in the evaluation for suspected acute coronary syndromes. Journal of the American College of Cardiology 37(2 Suppl A): 316A

Cohn, J.N. 2001: Optimal diuretic therapy for heart failure. American Journal of Medicine 111(7): 577

Li, Tat Wing F.; In Son Leong; Chi Man Leung; Wai Cheung Lao; Yiu Wing Luk 2000: Optimal dosage of propranolol for prevention of variceal in Chinese cirrhotic patients. Hepatology 32(4 Pt 2): 517A

Kurosawa, S.; Ogihara, S.; Mizuta, K.; Yakabi, K.; Nakamura, T. 2000: Optimal dosage of rabeprazole 10mg vs 20mg for the treatment of H2RA-resistant GERD patients determined by 24-hour esophageal pH monitoring. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1263

Watarida, S.; Li, R.K.; Weisel, R.D.; Mickle, D.A.G.; Tumiati, L.C.; Sakakibara, Y.; Yau, T.M. 1999: Optimal dose and timing of L-arginine administration in ischemia and reperfusion. Circulation 100(18): 1; 590

Rossing, K.; Christensen, P.K.; Jacobsen, P.K.; Hansen, B.V.; Parving, H.H.nrik 2002: Optimal dose for renoprotection by the angiotensin II receptor blocker candesartan in patients with type 2 diabetes and nephropathy. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 653A

Andersen, S.; Rossing, P.; Juhl, T.R.; Parving, H.H. 2000: Optimal dose of Losartan for renoprotection and blood pressure reduction in diabetic nephropathy. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 112A

Oliveras, A.; Vazquez, S.; Hurtado, S.; Puig, J.M.; Mir, M.; Lloveras, J. 2002: Optimal dose of doxazosin-GITS in hypertensive renal transplant patients Effect of 3 mg vs 4 mg. American Journal of Hypertension 15(4 Part 2): 44A-45A

Pussell, B.A.; Walker, R. 2003: Optimal dose of epoetin alfa for hemodialysis patients before and after switch from subcutaneous to intravenous administration. Journal of the American Society of Nephrology 14(Abstracts Issue): 268A

Peyton, J.; Murphy, M.B.; Kitabchi, A.E. 2000: Optimal dose of insulin for the treatment of diabetic ketoacidosis. Journal of Investigative Medicine 48(1): 114A

Poon, I.; Lee, N.; Akazawa, P.; Quivey, J.M.; Verhey, L.; Xia, P. 2001: Optimal dose/volume constraints of sensitive structures in inverse planning for nasopharyngeal carcinoma. International Journal of Radiation Oncology Biology Physics 51(3 Suppl 1): 395

Basser, R. 2001: Optimal doses of chemotherapy in adjuvant therapy of breast cancer. Breast 10(Suppl 1): S8-S9

Kawaguchi, Y.; Yamada, Y.; Tajima, K.; Oyama, K.; Azuma, R.; Wierzba, K.; Matsuo, K.; Kobunai, T.; Yamamoto, Y. 2001: Optimal dosing method of TAS-103, a novel quinoline derivative inhibiting DNA topoisomerases. Proceedings of the American Association for Cancer Research Annual Meeting 42: 102-103

Roskos, L.; Lohner, M.; Osborn, K.; Pasumarti, R.; Lu, H.; Funelas, C.; Raie, N.; Yang, X.D.; Weiner, L.; Figlin, R.; Belldegrun, A.; Crawford, J.; Schwab, G. 2002: Optimal dosing of ABX-EGF in cancer patients. International Journal of Cancer Suppl (13): 444

Dyke, C.K.; Mahaffey, K.W.; Berdan, L.G.; Ohman, M.; Newby, K.; Sparapani, R.A.; Berger, P.B.; Kleiman, N.S.; White, H.D.; Hochman, J.S.; Van, D.W.rf, F.; Armstrong, P.W.; Califf, R.M.; Harrington, R. 2001: Optimal dosing of a glycoprotein IIb/IIIa antagonist with a simplified renal-based algorithm Pharmacodynamic and clinical findings from PARAGON B. Journal of the American College of Cardiology 37(2 Suppl A): 343A-344A

Fasola, C.G.; Netto, G.J.; Christensen, L.L.; Sanchez, E.Q.; Molmenti, E.M.; Gonwa, T.A.; Goldstein, R.M.; Levy, M.F.; Klintmalm, G.B. 2001: Optimal dosing of mycophenolate mofetil is necessary to delay hepatitis C recurrence in liver transplant recipients. Hepatology 34(4 Pt 2): 639A

Yanagisawa, M.; Ouchi, K.F.; Tanaka, Y. 2003: Optimal dosing schedule for combination therapy with capecitabine and irinotecan in a human colorectal cancer xenograft model. EJC Suppls 1(5): S81-S82

Ogura, K.; Yoshida, H.; Maeda, S.; Yamaji, Y.; Mitsuno, Y.; Akanuma, M.; Hirata, Y.; Okamoto, M.; Kawabe, T.; Shiratori, Y.; Omata, M. 2000: Optimal duration for triple therapy against non-resistant strains of Helicobacter pylori. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1286

Segel, S.; Miles, A.; Clothier, B.; Parry, S.; Macones, G. 2002: Optimal duration of antibiotic therapy after PPROM. American Journal of Obstetrics and Gynecology 187(6 Suppl): S72

D'Angelo, A.; Piovella, F. 2002: Optimal duration of oral anticoagulant therapy after a first episode of venous thromboembolism: where to go?. Haematologica 87(10): 1009-1012

Steinhubl, S.R.; Darrah, S.; Brennan, D.; Mcerlean, E.; Berger, P.B.; Topol, E.J. 2003: Optimal duration of pretreatment with clopidogrel prior to PCI Data from the CREDO Trial. Circulation 108(17): IV374

Hortobagyi, G.N. 2001: Optimal duration of therapy with trastuzumab. Seminars in Oncology 28(5 Suppl 16: 33-40

Lobel, E.Z.; Korelitz, B.I.; Xuereb, M.A.; Panagopoulos, G. 2000: Optimal duration of treatment with 6-mercaptopurine for ulcerative colitis. American Journal of Gastroenterology 95(9): 2541

Joseph, S.; Gopal, A.S.; Krishnaswamy, R.R.; Toole, R.S.; Petillo, F.; Schapiro, W.; Reichek, N. 2004: Optimal echocardiographic method for determination of right ventricular volumes and systolic function. Journal of the American College of Cardiology 43(5 Suppl A): 343A

Richardson, K.R.; Chun, S.; Froelicher, V. 2003: Optimal electrocardiographic prediction of cardiovascular mortality. Journal of the American College of Cardiology 41(6 Suppl A): 104A

Honda, Y.; Grube, E.; Kataoka, T.; Hauptmann, K.E.; Morino, Y.; Hur, S.H.; Yock, P.G.; Fitzgerald, P.J. 2002: Optimal endpoint for Drug-eluting stent Predictive value of minimum stent area for long-term stent patency. Journal of the American College of Cardiology 39(5 Suppl A): 71A

O'buckley, T.; Alt, E.; Deno, D.C.; Rosborough, J. 1999: Optimal energy field distribution determined by catheter mapping. Journal of the American College of Cardiology 33(2 Suppl A): 106A

Brakmann, S. 2004: Optimal enzymes for single-molecule sequencing. Current Pharmaceutical Biotechnology 5(1): 119-126

Sugiyama, M.; Ogawa, H. 2000: Optimal estimation of values of functions at points of interest by model selection. Neuroscience Research Suppl (24): S37

Alon, U.S.; Alon, M. 2003: Optimal evaluation and treatment of pediatric idiopathic urolithiasis. Pediatric Research 53(4 Part 2): 517A

Houck, D.; Abrams, B.; Bishop, J.E.; Davis, K.; Hoffman, R. 2000: Optimal excitation intensity for leukocyte immunofluorescence. Cytometry Suppl (10): 166

Chen, J.G.; Mei, S.; Fu, Y.; Hu, X. 2003: Optimal experimental conditions for establishing a diabetic model with alloxan in ICR mice. Toxicology 191(1): 59, September 15th

Abdelmassih, S.; Brasil, A.; Santos, A.C.O.; Abdelmassih, R.; Diamond, M.; Dozortsev, D. 2003: Optimal fertilization window in humans is about 4 hours. Fertility and Sterility 80(Suppl 3): S293

Gardosi, J.O. 2000: Optimal fetal growth Method of prediction and clinical relevance. Acta Medica Auxologica 32(1): 49-50

Ferber, A.; Peleg, D.; Bar-Hava, I.; Orvieto, R.; Ben-Rafael, Z. 1999: Optimal fetal outcome despite persistent sinusoidal pattern after external cephalic version. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 19(3): 314-315

Das, S.K.; Sibley, G.S.; Munley, M.T.; Marks, L.B. 1999: Optimal field arrangements for stage I nonsmall cell lung cancer. International Journal of Radiation Oncology Biology Physics 45(3 Suppl): 380-381

Gong, Y.; Symmans, W.F.; Krishnamurthy, S.; Patel, S.; Sneige, N. 2003: Optimal fixation condition for immunocytochemical analysis of estrogen receptor in cytology specimens of breast cancer. Modern Pathology 16(1): 66A

Hagino, I.; Forbess, J.M.; Anttila, V.; Zurakowski, D.; Lidov, H.G.; Jonas, R.A. 2003: Optimal flow rate for selective cerebral perfusion during deep hypothermic cardiopulmonary bypass in piglets. Circulation 108(17): IV550

Hoffmeister, T.S. 2001: Optimal foraging in clustered patches. Zoology (Jena) 103(Suppl 3): 43

Daigneault,A.J.; Miranda,M.J.; Sohngen,B. 2010: Optimal forest management with carbon sequestration credits and endogenous fire risk. Land Economics: 1, 155-172

Li, S.; Jackson, J.; Williams, J. 2002: Optimal fractionated stereotactic radiotherapy of brain metastases. International Journal of Radiation Oncology Biology Physics 54(2 Suppl): 337-338

Brenner, D.J.; Schiff, P.B.; Hall, E.J. 2000: Optimal fractionation and protraction for radiotherapy of prostate cancer. Cancer Journal 6(2): 113

Nowak, T.V. 2000: Optimal gastric biopsy localization in Helicobacter pylori infection. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1285

Miller, L.D.; Long, P.M.; Wong, L.; Mukherjee, S.; McShane, L.M.; Liu, E.T. 2002: Optimal gene expression analysis by microarrays. Cancer Cell 2(5): 353-361

Ako, J.; Morino, Y.; Terashima, M.; Honda, Y.; Sonoda, S.; Leon, M.B.; Moses, J.W.; Yock, P.G.; Fitzgerald, P.J.; Sirius Investigators 2004: Optimal geometry is still important with sirolimus-eluting stents Incomplete stent expansion as a risk for target lesion revascularization. Journal of the American College of Cardiology 43(5 Suppl A): 84A

Hironori, M.; Hiroshi, K.; Yasuo, S.; Hisako, T. 2002: Optimal glycemic control at coronary stenting reduces restenosis in diabetics. Circulation 106(19): II561

Corpus, R.A.Jr; George, P.B.; Ajluni, S.C.; Devlin, W.H.; Timmis, G.C.; O'neill, W.W. 2001: Optimal glycemic control is associated with lower rates of target vessel revascularization in diabetics undergoing elective percutaneous coronary intervention. Journal of the American College of Cardiology 37(2 Suppl A): 66A

Corpus, R.A.; George, P.B.; Ajluni, S.; Pica, M.; O'neill, W.W. 2000: Optimal glycemic control reduces rate of target vessel revascularization in diabetic patients undergoing percutaneous coronary intervention. American Journal of Cardiology 86(Suppl 8A): 46i-47i

Collan, Y.; Ikpatt, O.F.; Kronqvist, P.; Kuopio, T. 2002: Optimal grading of breast cancer in different populations. Analytical Cellular Pathology 24(6): 200-201

Williams, C.K.; Lutz, S.; Applegate, R.D. 2001: Optimal group size and Northern Bobwhite coveys. Ecological Society of America Annual Meeting Abstracts 86: 235

Yerushalmi, R.; Shpall, E.J.; Childs, C.; Mcniece, I. 2000: Optimal growth of dendritic cells from CD34+ requires serum containing media. Experimental Hematology 28(7 Suppl 1): 89-90

Sindoni, M.J.; Matta, F.B. 2000: Optimal harvest time and effect of storage time on quality of apples grown in Mississippi. HortScience 35(4): 556

Milutinovic, S.; Milutinovic, E.; Krpan, D.; Drenovac, M. 1999: Optimal hemoglobin level for cognitive functioning in dialysis patients Is more better?. Nephrology Dialysis Transplantation 14(9): A260

Itri, L.M. 2000: Optimal hemoglobin levels for cancer patients. Seminars in Oncology 27(2 Suppl 4: 12-15; Discussion: 16-17

Goktas, S.; Crawford, E.D. 1999: Optimal hormonal therapy for advanced prostatic carcinoma. Seminars in Oncology 26(2): 162-173

Buscombe, J.R.; El Haddad, K.; Caplin, M.E.; Hilson, A.J. 2000: Optimal imaging of disseminated neuroendocrine tumours. Journal of Nuclear Medicine 41(5 Suppl): 301P

Amthor, F.R. 2000: Optimal imaging of ganglion cell dendritic responses of rabbit retinal ganglion cells in isolated retina. IOVS Investigative Ophthalmology and Visual Science 41(4): S937

E.H.ddad, E.S.; Tibballs, J.M.; Watkinson, A.J.; Irwin, A.G.; Caplin, M.E.; Buscombe, J.R.; Hilson, A.J.W. 2001: Optimal imaging of liver disease in neuroendocrine tumour. Journal of Nuclear Medicine 42(5 Suppl): 27P

Kurdziel, K.A.; Kalen, J.D.; Olsson, C.L.; King, L.D. 2000: Optimal imaging time for lung tumors on hybrid PET systems. Journal of Nuclear Medicine 41(5 Suppl): 183P

Stratta, R.J. 1999: Optimal immunosuppression in pancreas transplantation. Transplantation Proceedings 31(1-2): 619-621

Rockx, M.A.; Pflugfelder, P.W.; Kostuk, W.J. 2003: Optimal immunosuppression post cardiac transplantation Clinical outcomes of long-term cyclosporine monotherapy in a large patient population. Journal of Heart and Lung Transplantation 22(1s): S119

Guagliumi, G.; Virmani, R.; Valsecchi, O.; Camrud, A.R.; Scuri, P.M.; Armati, B.; Jones, R.; Kotevski, V.; Manazzale, V.; Camrud, L.J.; Epis, E.; Schwartz, R.S. 1999: Optimal implantation technique for self-expanding nitinol stents Less acute traumatic expansion and slow growth over time result in a larger final coronary lumen. Circulation 100(18): 1; 293

Vincent, P.W.; Patmore, S.J.; Atkinson, B.E.; Bridges, A.J.; Kirkish, L.S.; Dudeck, R.C.; Leopold, W.R.; Zhou, H.; Elliott, W.L. 1999: Optimal in vivo treatment schedule for the novel EGF receptor family tyrosine kinase inhibitor, PD183805, correlates with the inhibition of receptor tyrosine phosphorylation. Proceedings of the American Association for Cancer Research Annual Meeting 40: 117

Defrain, J.M.; Shirley, J.E.; Titgemeyer, E.C.; Park, A.F.; Ethington, R.T. 2001: Optimal inclusion level of a raw soybean hull-corn steep liquor pellet in diets for lactating dairy cows. Journal of Dairy Science 84(Suppl 1): 419

Gross, J.B. 1999: Optimal infusion rates for thiopental and propofol based on time course of ventilatory depression. Anesthesiology 91(3A): A1353

Kastrati, A.; Elezi, S.; Schuehlen, H.; Mehilli, J.; Dirschinger, J.; Neumann, F.J.; Schoemig, A. 1999: Optimal instead of high balloon pressure dilatation during coronary stent placement. Journal of the American College of Cardiology 33(2 Suppl A): 58A

Jones, S.; Quarry Horn, J.; Mauger, D.; Fedako, P.; Gabbay, R. 2003: Optimal insulin pump dosing and postprandial glycemia following a consistent pizza meal. Diabetes 52(Suppl 1): A534

Taylor, R.; Davies, R.; Fox, C.; Sampson, M.; Weaver, J.; Wood, L. 1999: Optimal insulin treatment for Type 2 diabetes A multicentre, randomised crossover study. Diabetes 48(Suppl 1): A112

Colleoni, M.; Goldhirsch, A. 2004: Optimal integration of chemo-endocrine treatment. EJC Suppls 2(3): 119-120

Minematsu, K.; Yasaka, M.; Yamaguchi, T. 1999: Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation A prospective, randomized, multicenter trial. Stroke 30(1): 241

Krittathanmakul, S.; Wongpoowarak, W. 2002: Optimal international normalized ratio in Thai patients with mitral valve replacement. Pharmacotherapy 22(10): 1345

Schiele, F.; Seronde, M.F.; Gupta, S.; Meneveau, N.; Vuillemenot, A.; Pales Espinosa, D.; Bassand, J.P. 1999: Optimal intravascular ultrasound criteria for stent deployment Comparison of different ultrasound criteria on the 6 months restenosis rate. Journal of the American College of Cardiology 33(2 Suppl A): 101A

Kron, S.S. 2004: Optimal intubating dose of succinylcholine. Anesthesiology 100(6): 1628; author reply 1628-9

Wright, B. 1999: Optimal kinematics of flapping wing/fin propulsion. American Zoologist 39(5): 56A

Rossi,M.; Guzzetti,F.; Reichenbach,P.; Mondini,A.C.; Peruccacci,S. 2010: Optimal landslide susceptibility zonation based on multiple forecasts. Geomorphology 4(3): 129-142

Encinias, A.M.; Loe, E.R.; Bauer, M.L.; Lardy, G.P.; Caton, J.S. 2001: Optimal level of rumen degradable protein in high-grain diets fed to feeder lambs. Journal of Animal Science 79(Suppl 2): 141

Corners, J.B.; Barnhart, K.J.; Ellersieck, M.; Williams, J.E. 2002: Optimal level of supplemental distillers dried grains plus solubles for heifers grazing tall fescue pastures. Journal of Dairy Science 85(Suppl 1): 234

Check, J.H. 2001: Optimal levels of LH, or not enough power to say?. Fertility and Sterility 76(4): 853

Gosukonda, R.M.; Singh, M.; Yadav, A.K. 2001: Optimal levels of antibiotics to eliminate Agrobacterium and in vitro selection in guava. HortScience 36(3): 535

Vinke, T.; Vinke, S. 2000: Optimal living conditions and breeding of Geochelone carbonaria from the Guiana Region. Salamandra 36(4): 233-246, 31 Dezember

Lund, R.; Davis, H.P.; Dolny, D.G. 2001: Optimal loading for lower extremity power output in male subjects. Medicine and Science in Sports and Exercise 33(5 Suppl): S332

Mathew, T.H. 1999: Optimal long-term immunotherapy protocols. Transplantation Proceedings 31(1-2): 1102-1103

Paraf, F.; Sabourin, J.C. 2000: Optimal lymph node number and occult lymph node metastases in colorectal cancer: the pathologist's view. Gastroenterologie Clinique et Biologique 24(4): 423-429

Rudolph, J.A.; Ryckman, F.C.; Balistreri, W.F.; Bucuvalas, J.C. 1999: Optimal management of biliary atresia A comparison of observed versus expected outcomes. Pediatric Research 45(4 Part 2): 117A

Mokany,K.; Moore,A.D.; Graham,P.; Simpson,R.J. 2010: Optimal management of fertiliser and stocking rate in temperate grazing systems. Animal Production Science: 1, 6-16

Heyborne, K.; Garite, T.; Porreco, R.; Abril, D.; Phair, K. 2003: Optimal management of monoamniotic twins. American Journal of Obstetrics and Gynecology 189(6 Suppl): S123

Faivre, S.; Janot, F.ço.; Armand, J.-P. 2004: Optimal management of nasopharyngeal carcinoma. Current Opinion in Oncology 16(3): 231-235

D.F.lippo, S.; Sassolas, F.; Bozio, A. 2002: Optimal management of neonates with large ventricular septal defect and aortic coarctation. European Heart Journal 23(Abstract Suppl): 154

Anderson, C.; Filsoufi, F.; Farivar, R.S..; Adams, D.H.. 2001: Optimal management of severe tricuspid regurgitation in cardiac transplant recipients. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 20(2): 247

Knight, B.P.; Morady, F. 1999: Optimal management of the patient with an episode of atrial fibrillation in and out of the hospital: acute cardioversion or not?. Journal of Cardiovascular Electrophysiology 10(3): 425-432

Miller, J.M.; Jayachandran, J.V.; Coppess, M.A.; Olgin, J.E. 1999: Optimal management of the patient with chronic atrial fibrillation: whom to cardiovert?. Journal of Cardiovascular Electrophysiology 10(3): 442-449

Li, Q.L.; Guan, H.W.; Zhang, Q.P.; Xue, J.; Song, X.S. 2002: Optimal margins in nephron-sparing surgery for renal cell carcinoma. European Urology Suppls 1(1): 26

Delimitreva, S.; Markova, M.; Zhivkova, R. 1999: Optimal metaphase plate preparation in mouse oocytes requires specific conditions for spindle disintegration. Dokladi na B"lgarskata Akademiya na Naukite 52(7-8): 105-108

Nishi, H.; Miyamoto, S.; Takanashi, S.; Minamimura, H.; Ishikawa, T.; Kato, Y.; Shimizu, Y. 2005: Optimal method of coronary endarterectomy for diffusely diseased coronary arteries. Annals of Thoracic Surgery 79(3): 846

Suh, J.Y.; Sohn, C.I.; Sung, I.K.; Jeon, W.K.; Kim, B.I. 2003: Optimal midazolam dose, factors affecting midazolam dose and proper timing of flumazenil injection during esophagogastroduodenoscopy. American Journal of Gastroenterology 98(9 Suppl): S282

Everts, H.B.; Berdanier, C.D. 1999: Optimal mitochondrial function in mitochondrial diabetes depends on a three fold increase in dietary vitamin A. Diabetes 48(Suppl 1): A6

Narayanan, U.G.; Allen, V.; Krahn, M.D. 2000: Optimal mode of delivery for infants with a prenatal diagnosis of spina bifida A decision analysis. Developmental Medicine and Child Neurology 42(Suppl 83): 11-12

Thomas, D.; Suthanthiran, M. 2003: Optimal modes and targets of gene therapy in transplantation. Immunological Reviews 196: 161-175

Wolpert, D.M.; Harris, C.M. 1999: Optimal motor control in the presence of signal-dependent noise A unifying hypothesis. Society for Neuroscience Abstracts 25(1-2): 1301

Cohen, G.; Shirai, T.; Weisel, R.D.; Rao, V.; Merante, F.; Tumiati, L.C.; Mohabeer, M.K.; Borger, M.A.; Li, R.K.; Mickle, D.A. 1999: Optimal myocardial preconditioning in humans. Annals of the new York Academy of Sciences 874: 306-319

Stankiewicz, B.J.; Legge, G.E.; Mansfield, J.S. 2000: Optimal navigation strategies with varying visual input. IOVS Investigative Ophthalmology and Visual Science 41(4): S44

Studen, M.; Stenzl, A.; Hobisch, A.; Bartsch, G. 2000: Optimal nerve-sparing during radical prostatectomy and cystectomy with a new surgical device. European Urology 37(Suppl 2): 99

Kasprzak, J.D.; Peruga, J.Z.; Drozdz, J.; Kurpesa, M.; Plewka, M.; Kidawa, M.; Rafalska, K.; Krzeminska Pakula, M. 1999: Optimal noninvasive quantification of proximal coronary artery stenosis with transesophageal echocardiography 2-Dimensional, peak velocity or continuity-based approach?. Journal of the American College of Cardiology 33(2 Suppl A): 474A

Shoham, S.; Maynard, E.M.; Normann, R.A. 1999: Optimal nonlinear filtering for directionally tuned neurons. Society for Neuroscience Abstracts 25(1-2): 1410

Beltrame, R.T.; Barioni, L.G.; Veloso, R.V.; Saueressig, M.G. 2003: Optimal number of recipient females in embryo transfer programs. Revista Brasileira de Reproducao Animal 27(3): 463-464

Shiran, M.R.; Rostami Hodjegan, A.; Abdul Manap, R.; Lennard, M.S.; Tucker, G.T. 2003: Optimal number of subjects and sampling time to assess CYP2D6 activity using the plasma dextromethorphan/dextrorphan metabolic ratio. British Journal of Clinical Pharmacology 55(4): 439-440

Pasternak, R.C. 2003: Optimal nutrition for the prevention of coronary heart disease: a worldwide challenge. Ethnicity and Disease 13(2 Suppl. 2): S91-S96

Bland, J. 1999: Optimal nutritional supplement for men. Official Gazette of the United States Patent and Trademark Office Patents 1224(2)

Prieto,C.A.; Guadix,E.M.; Guadix,A. 2010: Optimal operation of a protein hydrolysis reactor with enzyme recycle. Journal Of Food Engineering: 1, 24-30

Zschokke, S. 2001: Optimal orb-web constructing. Advances in Ethology 36: 294

Kausik, S.J.; Leibovich, B.C.; Cheng, L.; Weaver, A.L.; Myers, R.P.; Bostwick, D.G. 1999: Optimal outcome prediction after radical prostatectomy. Journal of Urology 161(4 Suppl): 238

Velez Roa, S.; Ciarka, A.; Rhanama, M.; Kojonazarov, B.; Dagonnier, M.; Degaute, J.P.; Van, D.B.rne, P. 2002: Optimal oxygenation is important in patients receiving dobutamine because this drug markedly enhances chemoreflex sensitivity to hypoxemia. European Heart Journal 23(Abstract Suppl): 173

Soltanian-Zadeh, H.; Windham, J.P. 1999: Optimal partial volume estimation in MRi. Magnetic Resonance in Medicine 42(3): 612-615

Kobe, R.K.; Iyer, M.; Walters, M.B. 2010: Optimal partitioning theory revisited: nonstructural carbohydrates dominate root mass responses to nitrogen. Ecology 91(1): 166-179

Van Der Velde, E.T.; Atsma, D.E.; Brobbel, C.; Witteman, T.A.; Schalij, M.J. 2001: Optimal patient care at the CCU by the use of a wireless data entry and retrieval device and dedicated electronic patient record system. European Heart Journal 22(Abstract Suppl): 381

Johnson, J.; Colombo, D.; Gardner, D.; Cho, E.; Fan Havard, P.; Shellhaas, C. 2001: Optimal penicillin dosing for group B Streptococcus prophylaxis. American Journal of Obstetrics and Gynecology 184(1): S15

Johnston, S.D.; Mcgowan, M.R.; Phillips, N.J.; O'callaghan, P. 2000: Optimal physicochemical conditions for the manipulation and short-term preservation of koala spermatozoa. Journal of Reproduction and Fertility 118(2): 273-281

Parker, M.L.; Arnold, W.S.; Marelli, D.C. 2003: Optimal planting conditions for maximum reproductive output of cage-planted scallops, Argopecten irradians, in Anclote, Florida. Journal of Shellfish Research 22(1): 348

Kim, J.S.; Kashuba, A.D.M.; Nafziger, A.N.; Rocci, M.L.Jr.; Kulawy, R.W.; Beck, D.J.; Bertino, J.S.Jr 1999: Optimal plasma sampling to predict AUC of the CYP3A probe midazolam. Clinical Pharmacology and Therapeutics 65(2): 185

Gusler, G.; Berner, B.; Chau, M.; Padua, A. 2004: Optimal polymer mixtures for gastric retentive tablets. Official Gazette of the United States Patent and Trademark Office Patents 1281(3)

Creamer, K.; McCloud, L.; Fisher, L.; Ehrhart, I. 1999: Optimal positive end-expiratory pressure fails to preserve nonrespiratory lung function in acute lung injury. Chest 116(1 Suppl): 16S-17S

Remzi, M.; Djavan, B.; Seitz, C.; Zlotta, A.; Schulman, C.; Marberger, M. 1999: Optimal predictors of prostate cancer in repeat prostate biopsy A prospective study in 1051 men. Journal of Urology 161(4 Suppl): 323

Schenk, S.; Popovic, Z.B.; Mccarthy, P.M.; Ochiai, Y.; Starling, R.C.; Navia, J.L.; Ootaki, Y.; Kamohara, K.; Thomas, J.D.; Fukamachi, K. 2004: Optimal preload adjustment of right ventricular power allows for single beat estimation of contractility. Journal of the American College of Cardiology 43(5 Suppl A): 219A

Mesquita, M.M.F.; Stimson, J.; Chae, G.-T.; Tufenkji, N.; Ptacek, C.J.; Blowes, D.W.; Emelko, M.B. 2010: Optimal preparation and purification of PRD1-like bacteriophages for use in environmental fate and transport studies. Water Research 44(4): 1114-1125

Nomura, L.E.; deHaro, E.D.; Martin, L.N.; Maecker, H.T. 2003: Optimal preparation of rhesus macaque blood for cytokine flow cytometric analysis. Cytometry. Part A: the Journal of the International Society for Analytical Cytology 53(1): 28-38

Piccart, M.J.; Demonty, G.; Dal Lago, L.; Dolci, S.; Straehle, C. 2004: Optimal primary treatment of patients with an HER2 overexpressing tumour. EJC Suppls 2(3): 158

Herrnstadt, C.; Ghosh, S.; Fahy, E.D.; Davis, R.E. 2000: Optimal procedure for isolation of mutant mitochondrial alleles. Official Gazette of the United States Patent and Trademark Office Patents 1231(4)

Kreindel, M.; Eckhouse, S. 2000: Optimal procedure for performing a hair removal. Official Gazette of the United States Patent and Trademark Office Patents 1241(3)

Eikmans, Michael; Baelde, Hans J.; De Heer, Emile; Bruijn, Jan A. 1999: Optimal procedure for quantitation of collagen alpha1 mRNA steady-state levels in fresh and stored human renal biopsy tissue. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 570A

Bayer Zwirello, L.A.; Hoffman, D.; Adams, L.; Bsat, F.; Patel, S.; Reece, M. 2001: Optimal processing of umbilical cord blood for retrieval of white blood A comparison of methods. American Journal of Obstetrics and Gynecology 184(1): S92

Kim, E.Y.; Park, P.K.; Chae, H.J. 1999: Optimal production conditions and characterization of extracellular lipid produced by Rhodotorula glutinis. Abstracts of Papers American Chemical Society 217(1-2): BIOT 128

Yamazaki, T.; Engel, G.; Watt, C.; Myers, J.; Chun, S.; Froelicher, V.F. 2004: Optimal prognostication from the 12-lead ECG Spatial angle between the QRS and T wave complexes. Journal of the American College of Cardiology 43(5 Suppl A): 150A

Hata, M.; Shiono, M.; Sekino, H.; Furukawa, H.; Inoue, T.; Sezai, A.; Niino, T.; Negishi, N.; Sezai, Y. 2003: Optimal protective treatment for gastrointestinal diseases after open heart surgery. Circulation 108(17): IV610-IV611

Ohuchi, H.; Hasegawa, S.; Yasuda, K.; Arakaki, Y.; Yagihara, T.; Echigo, S. 2000: Optimal pulmonary function and haemodynamics for maximal exercise capacity in patients after the Fontan operation. European Heart Journal 21(Abstract Suppl): 430

Hoskin, P.J.; Grover, A.; Bhana, R. 2002: Optimal radiotherapy dose for metastatic spinal canal compression. British Journal of Cancer 86(Suppl 1): S20

Bernier, J. 2001: Optimal radiotherapy in head and neck tumours From biology to physics. European Journal of Cancer 37(Suppl 6): S247

Yang, X.; Marchand, J.E. 2002: Optimal ratio of degenerate primer pairs improves specificity and sensitivity of PCR. Biotechniques 32(5): 1002; 1004, 1006

Imran, M.B.; Pálinkás, A.; Pasanisi, E.M.; De Nes, M.; Picano, E. 2002: Optimal reading criteria in stress echocardiography. American Journal of Cardiology 90(4): 444-445

Sanz, J.; Rius, T.; Kuschnir, P.; Salguero, R.; Fuster, V.; Poon, M. 2004: Optimal reconstruction protocol for noninvasive coronary angiography with 16-slice multidetector-row computed tomography. Journal of the American College of Cardiology 43(5 Suppl A): 329A

Masoumi, F.; Kerachian, R. 2010: Optimal redesign of groundwater quality monitoring networks: a case study. Environmental Monitoring and Assessment 161(1-4): 247-257

Faria,P.J.; Oosterhout,C.van; Cable,J. 2010: Optimal release strategies for captive-bred animals in reintroduction programs experimental infections using the guppy as a model organism. Biological Conservation 3(1): 35-41

Masotti, M.; Betriu, A. 2001: Optimal reperfusion in evolving myocardial infarction Does abciximab improve outcomes in stent treated patients?. European Heart Journal 22(Abstract Suppl): 475

Nielsen, L.R.; Jørgensen, E.; Kristensen, A.R.; Ostergaard, S. 2010: Optimal replacement policies for dairy cows based on daily yield measurements. Journal of Dairy Science 93(1): 75-92

Yang, J.C.; Kuo, Y.N.; Wang, T.H. 2001: Optimal rescue therapy for Helicobacter pylori infection after failure of PPI-based triple therapies. Gut 49(Suppl 11): A86

Kontaxakis, V.P.; Havaki Kontaxaki, B.J.; Stamouli, S.S.; Christodoulou, G.N. 2000: Optimal risperidone dosage in drug-naive first-episode schizophrenic patients. European Neuropsychopharmacology 10(Suppl 3): S311

Boyd, A.V.; Pai, A.B.; Tinklenberg, A.; Townsend, K.; Spalding, C. 2003: Optimal sampling for international normalized ratios in hemodialysis patients with central venous catheters. Journal of the American Society of Nephrology 14(Abstracts Issue): 729A

Cobanov, B.; St Pierre, N.R. 2003: Optimal sampling schedule of diet components. Journal of Dairy Science 86(Suppl 1): 285

Van Rossum, L.K.; Mathot, R.A.; Vulto, A.G. 2002: Optimal sampling strategies for the assessment of inulin clearance in children. Clinical Pharmacology and Therapeutics 71(2): P80

Flohr, T.; Suess, C.; Becker, C.; Kuettner, A.; Nieman, K.; Schaller, S.; Ohnesorge, B. 2002: Optimal scan protocols for ECG-gated 16-slice CT of the heart. Circulation 106(19): 2; 442

Nakamoto, Y.; Saga, T.; Higashi, T.; Ishimori, T.; Kobayashi, H.; Ishizu, K.; Sakahara, H.; Imamura, M.; Konishi, J. 2001: Optimal scan time for evaluating suspected pancreatic cancer with FDG-PET. Journal of Nuclear Medicine 42(5 Suppl): 29P

Shidahara, M.; Watabe, H.; Kim, K.; Nakamura, T.; Kato, T.; Ito, K.; IIda, H. 2002: Optimal scan time of 15O-labeled gas inhalation method for measurement of cerebral oxygen extraction fraction. Journal of Nuclear Medicine 43(5 Suppl): 211P

Kanzawa, F.; Koh, Y.; Tatsumi, Y.; Koizumi, F.; Nakamura, T.; Saijo, N.; Yoshioka, T.; Nishio, K. 2000: Optimal schedule of in vitro combination chemotherapy of nedaplatin and irinotecan and its mechanism of action. Proceedings of the American Association for Cancer Research Annual Meeting 41: 240

Dorsey, R.; Songer, T.; Zgibor, J. 2003: Optimal screening in type 1 diabetics. Diabetes 52(Suppl 1): A259-A260

Christie, G.C.; Young, R.J.; Cuddy, D.W.; Fodale, M.; Slade, J. 2000: Optimal selection of sea lamprey control options in the Great Lakes. IAGLR Conference Program and Abstracts 43: A - 22

Dekkers, J.C.M.; Chakraborty, R.; Moreau, L. 2001: Optimal selection on two quantitative trait loci with linkage. Journal of Dairy Science 84(Suppl 1): 26

Lebrec, J.; Putter, H.; Van Houwelingen, J.C. 2003: Optimal selection procedures for linkage analysis of complex traits. Genetic Epidemiology 25(3): 257-258

Tolcher, A.W.; Mooberry, S.L.; Southwell, T.; Mangold, G.; Rowinsky, E.K. 2003: Optimal sequence and schedule of oblimersen administration when combined with docetaxel in the PC3 human prostate tumor model. Proceedings of the American Association for Cancer Research Annual Meeting 44: 541

Prinzen, F.W.; Van Oosterhout, M.F.M.; Vanagt, W.Y.R.; Storm, C.; Reneman, R.S. 1999: Optimal sequence rather than minimal asynchrony of activation improves ventricular function during ventricular pacing. European Heart Journal 20(ABSTR Suppl ): 464

Schmidt, M.R.; Vogel, M.; Egeblad, H.; Mortensen, P.; Redington, A.N.; Sogaard, P. 2002: Optimal sequential resynchronization in biventricular pacing can be determined by isovolumic myocardial acceleration measured by tissue Doppler. Circulation 106(19): II556

Basavaraju, K.P.; Hegde, M.; Preston, J.; Ahluwalia, N.K. 2004: Optimal sites to biopsy for an accurate diagnosis of H pylori infection based on its topographical distribution using CLO test Body V antrum of the stomach. Gut 53(Suppl 3): A43

Arnedo, L.; Ahumada, J. 2004: Optimal size of feeding and traveling subgroups of spider monkey. American Journal of Physical Anthropology Suppl (38): 53-54

Khastagir,A.; Jayasuriya,N. 2010: Optimal sizing of rain water tanks for domestic water conservation. Journal Of Hydrology (amsterdam)1: 3 4, 181-188

Boruta, D.M.II.M.ller, K.A.; Zhou, C.; Boggess, J.F. 2002: Optimal specimen type and detection method for evaluation of telomerase activity and hTERT expression in cervical epithelium. Proceedings of the American Association for Cancer Research Annual Meeting 43: 745

Murawski, M.; Slavik, T.; Wierzchos, E.; Zieba, D. 2000: Optimal sperm co-incubation periods for in vitro fertilization of ovine oocytes. Theriogenology 53(1): 428

Castro Santos, T.; Haro, A. 2000: Optimal sprint speeds of fish traversing velocity barriers Further thoughts on burst-swimming data. American Zoologist 40(6): 968

Cavanaugh, J.R.; Bair, W.; Movshon, J.A. 1999: Optimal stimulus size changes over time in macaque V1 neurons. Society for Neuroscience Abstracts 25(1-2): 1048

Hata, Mitsumasa; Et Al 2002: Optimal strategy of diagnosis and treatment for aortic dissection. Nichidai Igaku Zasshi 61(4): 117-120

D.R.za, G.; Chen, J.; Keown, P.; Jastrzebski, J. 2003: Optimal strategy of permanent vascular access creation in patients requiring acute initiation of dialysis Factors affecting ongoing access patency. Journal of the American Society of Nephrology 14(Abstracts Issue): 235A

Nijevitch, A.A.; Farztdinov, K.M.; Sataev, V.U.; Dashkova, S.; Kazykhanov, N.S. 2001: Optimal strategy of treatment of Helicobacter pylori infection: renaissance of antisecretory drugs?. American Journal of Gastroenterology 96(3): 921-922

Pasini, D.; Burgess, S.C. 2002: Optimal structural features in trees and their application in engineering. Brebbia, C A , Reprint Author, Sucharov, L J , Reprint Author, Pascolo, P Comparing design in nature with science and engineering: 3-15

Smolkin, M.E.; Hahn, L.W.; Haines, J.L.; Moore, J.H. 2001: Optimal study designs for detecting and replicating susceptibility loci using affected sib-pair linkage analysis. American Journal of Human Genetics 69(4 Suppl): 411

Lin, D.Y.; Liaw, Y.F. 2001: Optimal surveillance of hepatocellular carcinoma in patients with chronic viral hepatitis. Journal of Gastroenterology and Hepatology 16(7): 715-717

Cheryk, L.A.; Hoefner, D.M.; Velosa, J.A.; Moyer, T.P. 1999: Optimal tacrolimus steady state blood concentration for renal transplantation. Clinical Chemistry 45(6 Part 2): A68

Slattery, J.M. 2003: Optimal targeting of mydriasis in screening for diabetic retinopathy. Diabetes and Metabolism 29(Hors serie 2): 4S404-4S405

Hiraoka, K.; Trexler, A.; Fujioka, B.; Guo, Z.; Zhang, H.J.; Overland, A.; Oberbroeckling, J.; Sageshima, J.; Shibata, S.; Sutherland, D.E.; Hering, B.J. 2001: Optimal temperature in pancreas preservation by the two-layer cold storage method before islet isolation. Transplantation Proceedings 33(1-2): 891-892

Conti, C.R. 2000: Optimal therapeutic management of non-Q-wave myocardial infarction. Clinical Cardiology 23(1): 1-3

Leonard, G.D.; McCaffrey, J.A.; Maher, M. 2003: Optimal therapy for oesophageal cancer. Cancer Treatment Reviews 29(4): 275-282

Vergani, P.; Locatelli, A.; Ratti, M.; Scian, A.; Zani, G.; Pezzullo, J.; Ghidini, A. 2003: Optimal threshold of intertwin weight difference for the prediction of adverse neonatal outcome in twins delivered at 37 weeks. American Journal of Obstetrics and Gynecology 189(6 Suppl): S164

Vergani, P.; Locatelli, A.; Ghidini, A.; Strobelt, N.; Piccoli, M.G.; Ceruti, P.; Pezzullo, J.C. 1999: Optimal threshold of nuchal fold thickness to reduce the risk of down syndrome in women 35 years of age or older. American Journal of Obstetrics and Gynecology 180(1 Part 2): S163

Vergani, P.; Roncaglia, N.; Andreotti, C.; Pezzullo, J.; Ciriello, E.; Ghidini, A. 2002: Optimal threshold of umbilical artery PI for the prediction of adverse neonatal outcome in cases of fetal growth restriction delivered at gtoreq34 weeks gestation. American Journal of Obstetrics and Gynecology 187(6 Suppl): S164

Werner, G.S. 2003: Optimal thrombolysis for acute myocardial infarction Still opting for percutaneous intervention ?. DMW Deutsche Medizinische Wochenschrift 128(41): 2149-2152, 10 Oktober

Bolnick, A.; Egan, J.; Zelop, C.; Fiala, J.; Maffeo, C.; Whitsel, A.; Borgida, A. 2003: Optimal time for fetal anatomic survey by BMI and gestational age. American Journal of Obstetrics and Gynecology 189(6 Suppl): S232

Cantarovich, M.; Giannetti, N.; Cecere, R.; Fontaine, G.; Besner, J.G. 2004: Optimal time point to predict cyclosporine, tacrolimus and mycophenoic acid area-under-the-curve 0-12 hr in long-term heart/heart-lung transplant patients. Journal of Heart and Lung Transplantation 23(2S): S141

Tong, A.K.W.; Schaefer, A.L.; Zawadski, S.M. 2001: Optimal time to scan cattle after trucking using infrared radiometer. Canadian Journal of Animal Science 81(4): 619

Kuczynski, L.; Zduniak, P. 2003: Optimal timing and density-dependent factors influence nest survival in the hooded crow Corvus corone cornix. Vogelwarte 42(1-2): 81-82

Bando, K.; Okita, Y.; Ueda, Y.; Morita, S.; Kada, A.; Nishi, C.; Yagihara, T.; Kobayashi, J.; Kitamura, S. 2003: Optimal timing and late outcomes of aortic valve replacement for severe aortic regurgitation A multi-institutional study of a 25 year-experience. Circulation 108(17): IV620

Gerard, J.P.; Romestaing, P.; Mornex, F.; Chapet, O.; Freyer, G.; Francois, Y. 2000: Optimal timing between preoperative radiotherapy and surgery to improve sphincter preservation for rectal cancer. Radiotherapy and Oncology 56(Suppl 1): S52

Hicks, M.L.; Lonial, S.; Langston, A.; Smith, K.J.; Sai, S.M.; Hamilton, E.S.; Waller, E.K. 2003: Optimal timing for chemotherapy and cytokine mobilization of autologous blood hematopoietic progenitor cells. Blood 102(11): 419b

Therrien, J.; Provost, Y.; Merchant, N.; Williams, W.; Colman, J.; Webb, G. 2004: Optimal timing for pulmonary valve replacement in adults after tetralogy of fallot repair A magnetic resonance imaging study. Journal of the American College of Cardiology 43(5 Suppl A): 398A

Siniawski, H.; Weng, Y.; Pasic, M.; Yankah, C.; Hoffmann, M.; Stein, J.; Hetzer, R. 2002: Optimal timing for surgery of aortic root abscess depends on staging and extension of destructive endocarditis. Circulation 106(19): 2; 673-II 674

Cantarovich, M.; de Gruchy, S.; Forbes, C.; Marpole, D.; Elstein, E.; Magnan, C.; de Varennes, B. 1999: Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction. Transplantation Proceedings 31(1-2): 79

Paterson, C.J.; Mellen, B.G.; Chauvenet, A.R.; Mclean, T.W. 2002: Optimal timing of central venous line placement and CVL type in children with good prognosis acute lymphoblastic leukemia. Pediatric Research 51(4 Part 2): 232A

Sfakianakis, G.N.; Cole, C.; Georgiou, M.F.; Leveillee, R.J.; Strauss, J.; Abitbol, C.; Montane, B.S.; Zilleruelo, G.; Gosalbez, R.; Labbie, A.S. 1999: Optimal timing of diuretic administration in diuretic renography. Journal of Nuclear Medicine 40(5 Suppl): 51P

Thompson, M.A.; Sharma, V.; Simon, S.D.; Alon, U.S. 2003: Optimal timing of follow-up voiding cystourethrogram in children with primary vesicoureteral reflux. Journal of the American Society of Nephrology 14(Abstracts Issue): 197A

Rath, J.C.; Sepehrmanesh, D.D.; Reimer, P.; Kunzmann, V.; Schoettker, B.; Wilhelm, M.; Weissinger, F. 2003: Optimal timing of induction chemotherapy for mobilization of autologous stem cells. Blood 102(11): 417b

Tsuchiya, K.; Tada, M.; Shirato, H.; Hashimoto, S.; Nishioka, T.; Aoyama, H.; Kitamura, K.; Shimizu, S.; Omatsu, T.; Miyasaka, K. 2000: Optimal timing of introduction of wild-type p53 in gene-radiotherapy for glioblastoma predicted by a temperature-sensitive p53 mutant cell line. International Journal of Radiation Oncology Biology Physics 48(3 Suppl): 276

Cahill, B.C.; Liou, T.G.; Marshall, B.C.; Fitzsimmons, S.; Hoidal, J.R.; Adler, F.R. 1999: Optimal timing of lung transplantation cystic fibrosis patients. Journal of Heart and Lung Transplantation 18(1): 86

Ronner, E.; Boersma, E.; Harrington, R.A.; Lincoff, A.M.; Simoons, M.L. 1999: Optimal timing of percutaneous intervention in unstable angina. European Heart Journal 20(ABSTR Suppl ): 260

Lantz, M.; Chisholm, C. 2001: Optimal timing of second-trimester obstetrical ultrasound based on maternal body mass index. American Journal of Obstetrics and Gynecology 184(1): S147

Cheung, M.M.H.; Sullivan, I.D.; Elliott, M.J.; Deleval, M.R.; Hsia, T.Y.; Redington, A.N.; Tsang, V.T. 2000: Optimal timing of the Ross procedure in the young with chronic aortic incompetence. Circulation 102(18): 2; 651-II 652

Madden, K. 2002: Optimal timing of thrombolytic therapy in acute ischaemic stroke. Cns Drugs 16(4): 213-218

Kinuya, S.; Yokoyama, K.; Konishi, S.; Hiramatsu, T.; Li, X.F.; Michigishi, T.; Tonami, N. 2000: Optimal timing to administer hyperthermia in combined radioimmunotherapy. Journal of Nuclear Medicine 41(5 Suppl): 271P

Brown, G.R.; Wolfe, D.E. 2000: Optimal training of apple trees for high-density plantings. HortScience 35(4): 555

Kanat, A.; Yilmaz, A.; Aydin, Y. 2000: Optimal treatment for meningiomas. Journal of Neurosurgery 93(1): 153-155

Tomassetti, P.; Salomone, T.; Migliori, M.; Campana, D.; Corinaldesi, R. 2003: Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients. Drugs and Aging 20(14): 1019-1034

Marin, P.; Gubelin, G.; Urriola, J.; Vinambres, X.; Garces, M.; Jara, L. 2001: Optimal treatment of hypertension by assessing cardiovascular risk profile. Hypertension 37(3): 1024

Lauer, B.; Schmidt, E.; Ambrosch, H.; Diederich, K.; Hambrecht, R.; Krankenberg, H.; Kuhn, A.; Sick, P.; Zotz, R.; Schuler, G. 1999: Optimal treatment of in-stent-restenosis Excimerlaser-angioplasty, rotational atherectomy or conventional angioplasty?. Journal of the American College of Cardiology 33(2 Suppl A): 62A

Ting, E.C.; Anand, S.K. 2001: Optimal treatment of infantile hyponatremia caused by excessive water ingestion. Pediatric Research 49(4 Part 2): 98A

Berg, R.A.; Hilwig, R.W.; Kern, K.B.; Corso, E.V.; Heidenreich, J.W.; Ewy, G.A. 1999: Optimal treatment of prolonged VF in a swine model of prehospital cardiac arrest. Circulation 100(18): 1; 91

Kim, W.R.; Poterucha, J.J.; Dickson, E.R.; Gross, J.B.Jr 1999: Optimal treatment strategy for chronic hepatitis C in 1999. Gastroenterology 116(4 Part 2): A1230

Jaup, B.H. 2001: Optimal triple therapy for H pylori eradication in an area of high resistance to metronidazole A practical approach. Gut 49(Suppl 11): A94-A95

Morrow, D.A.; Rifai, N.; Hille, D.; Dibattiste, P.M.; Robertson, D.H.; Demopoulos, L.A.; Cannon, C.P. 2001: Optimal troponin I decision limits for management of ACS Observations from TACTICS-TIMI 18. Circulation 104(17): II708

Warnants, N.; Van Oeckel, M.J.; De Paepe, M.; Le Bellego, L.; Relandeau, C. 2002: Optimal true ileal digestible lysine dietary level in growing hybrid pigs. Journal of Dairy Science 85(Suppl 1): 132

Narsipur, S.S.; Madan, A. 1999: Optimal tuberculosis screening of hemodialysis patients. Nephron 82(4): 356

Netta, D.; Ananth, C.; Fuks, A.; Visintainer, P.; Verma, U.; Scorza, W. 2003: Optimal type of uterine incision in cesarean delivery of the low birth weight nonvertex fetus. American Journal of Obstetrics and Gynecology 189(6 Suppl): S142

MuLiQiang; LiuLiPing; MaDaLong 2010: Optimal ultrasonic extraction condition and determination of polysaccharides in Tilia amurensis flowers. Journal Of Forestry Research: 1, 77-80

Wehrli, G.; Schelonka, R.L. 2003: Optimal usage of dedicated packed red blood cell units in VLBW infants. Pediatric Research 53(4 Part 2): 281A

Talpur, R.; Chiao, N.; Duvic, M. 2003: Optimal use of extracorporeal photopheresis in cutaneous T cell Lymphoma. Journal of Investigative Dermatology 121(1): 1238

Leypoldt, J.K.; Cheung, A.K. 2002: Optimal use of hemodialyzers. Contributions to Nephrology 137: 129-137

Euscher, E.D.; Baker, P.B. 2001: Optimal use of postmortem cytogenetics. Laboratory Investigation 81(1): 6A

Hasegawa, A.; Takahashi, K.; Ito, K.; Oshima, S.; Uchida, K.; Sonoda, T. 2002: Optimal use of tacrolimus in living donor renal transplantation in children. Transplantation Proceedings 34(5): 1939-1941

Benson, A.B.; Goldberg, R.M. 2003: Optimal use of the combination of irinotecan and 5-fluorouracil. Seminars in Oncology 30(3 Suppl. 6): 68-77

Romppanen, E.L.; Savolainen, K.; Mononen, I. 2000: Optimal use of the fluorescent PicoGreen dye for quantitative analysis of amplified polymerase chain reaction products on microplate. Analytical Biochemistry 279(1): 111-114

Shankar, R. 2002: Optimal utilization of resources. Kashima, H, Falloon, I R H, Mizuno, M, Asai, M Keio University Symposia for Life Sciences and Medicine Comprehensive treatment of schizophrenia: Linking neurobehavioral findings to psychosocial approaches 222-231

Manfredi, P.; Posta, P.D.; d'Onofrio, A.; Salinelli, E.; Centrone, F.; Meo, C.; Poletti, P. 2009: Optimal vaccination choice, vaccination games, and rational exemption: an appraisal. Vaccine 28(1): 98-109

Groothuis, J.T.; Kooijman, M.; Van Vliet, L.; Hopman, M.T.E. 2003: Optimal venous cuff pressure for measuring limb arterial inflow by strain gauge plethysmography. Medicine and Science in Sports and Exercise 35(5 Suppl): S226

Zeytunlu, M.; Icoz, G.; Kiliç, M.; Yuzer, Y.; Tokat, Y. 2002: Optimal venous drainage for right lobe living donor liver grafts. Transplantation Proceedings 34(8): 3327-3330

Bax, J.J.; Vanoverschelde, J.L.uis J.; Cornel, J.H.; Elhendy, A.; Poldermans, D.; Boersma, E.; Fioretti, P.M. 1999: Optimal viability criteria on thallium-201 reinjection SPECT to predict improvement of function after revascularization. Journal of the American College of Cardiology 33(2 Suppl A): 416A

Darlow, B.A.; Buss, H.I.; Mcgill, F.; Mogridge, N.; Graham, P.; Winterbourn, C.C. 2003: Optimal vitamin C supplementation in very preterm infants A randomised controlled trial of three different regimes. Pediatric Research 53(4 Part 2): 421A

Wilson, J.W.; Vetter, E.A.; Torgerson, C.A.; Harmsen, W.S.; Ilstrup, D.M.; Wilson, W.R.; Cockerill, F.R. 1999: Optimal volume of blood, frequency of collection and incubation period for diagnosing blood stream infections. Abstracts of the General Meeting of the American Society for Microbiology 99: 208

Liu, C.S.J.; Miki, A.; Liu, G.T.; Haselgrove, J.C. 2001: Optimal voxel size for detection of fMRI activation of visual cortex. IOVS Investigative Ophthalmology and Visual Science 42(4): S408

Can, A.S.çu.; Yildiz, E.A.; Samur, G.ül.; Rakicioğlu, N.şa.; Pekcan, G.ül.; Ozbayrakçi, S.; Palaoğlu, K.E.; Gönen, M.; Bersot, T.P. 2010: Optimal waist:height ratio cut-off point for cardiometabolic risk factors in Turkish adults. Public Health Nutrition 13(4): 488-495

Kargol, A.; Millonas, M.M. 2000: Optimal waveform analysis of voltage-sensitive ion channel gating kinetics. Biophysical Journal 78(1 Part 2): 219A

Brem, H.; Balledux, J.; Bloom, T.; Kerstein, M.; Hollier, L.; Falanga, V. 2000: Optimal wound bed preparation for the successful use of bioengineered skin in venous ulcers. Wound Repair and Regeneration 8(5): A409

Overholser, B.R.; Sowinski, K.M. 2004: Optimal, sparse sampling times of anti-factor XA activity following subcutaneous enoxaparin administration in patients with chronic kidney disease. Clinical Pharmacology and Therapeutics 75(2): P40

Robins, J. 2002: Optimal-regime structural nested models. American Journal of Epidemiology 155(11 Suppl): S35

Cherniak, C.; Mokhtarzada, Z.; Nodelman, U. 2002: Optimal-wiring models of neuroanatomy. Ascoli, Giorgio A Computational Neuroanatomy: Principles and Methods 71-82

Paczuski, R. 2002: Optimalisation of measurement of von Willebrand factor activity with collagen binding assay. Acta Haematologica Polonica 33(3): 371-379

Oude Elberink, J.N.G.; De Jong, Y.P.; De Monchy, J.G.R.; Dubois, A.E.J. 1999: Optimalization of intradermal skin tests for detection of sensitization to yellow jacket venom. Journal of Allergy and Clinical Immunology 103(1 Part 2): S182

De Jong, Y.P.; Oude Elberink, J.N.G.; De Monchy, J.G.R.; Dubois, A.E.J. 1999: Optimalization of skin prick tests for detection of sensitization to yellow jacket venom. Journal of Allergy and Clinical Immunology 103(1 Part 2): S165

Nilsen, T.W. 2000: Optimally fluorescent oligonucleotides. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)

Greenwell, G.R. 2002: Optimally individualize rehabilitation Dont ever give up. Medicine and Science in Sports and Exercise 34(5 Suppl): S252

Nilsen, T.W. 2000: Optimally labeled oligonucleotides. Official Gazette of the United States Patent and Trademark Office Patents 1233(1)

Cho, K.D.; Kim, D.Y.; Park, D.W.; Jeon, H.R.; Kim, H.J. 2001: Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative. Official Gazette of the United States Patent and Trademark Office Patents 1249(4)

Bezborodyi, S.D. 2000: Optimation of anti-helicobacter therapy of peptic ulcer on the basis of modern methods of pharmacokinetic analysis. Klinicheskaya Laboratornaya Diagnostika 11: 37-39

Cardador, M.J.; Gallego, M. 2010: Optimisation and comparison of several microextraction/methylation methods for determining haloacetic acids in water using gas chromatography. Analytical and Bioanalytical Chemistry 396(3): 1331-1343

Suzen, S.; Parry, J.M. 1999: Optimisation and validation of Restriction Site Mutation assay for ras and p53 genes in the rat. Dizdaroglu, M, Karakaya, A E NATO ASI Series Series A Life Sciences; Advances in DNA damage and repair: Oxygen radical effects, cellular protection, and biological consequences: 480

Hick, P.; Whittington, R.J. 2010: Optimisation and validation of a real-time reverse transcriptase-polymerase chain reaction assay for detection of betanodavirus. Journal of Virological Methods 163(2): 368-377

Naidoo, S.; Theron, D.; Walford, S.; Murray, S.L.; Denby, K.J.; Berger, D.K. 2003: Optimisation experiments for Arabidopsis cDNA microarrays. South African Journal of Botany 69(2): 259

Khoo, V.S.; Bedford, J.L.; Webb, S.; Dearnaley, D.P. 2000: Optimisation of 3, 4, and 6-field coplanar beam arrangements for prostate conformal radiotherapy and dose escalation. Radiotherapy and Oncology 56(Suppl 1): S108

Khoo, V.S.; Bedford, J.L.; Webb, S.; Dearnaley, D.P. 2000: Optimisation of 3-, 4-, and 6-field coplanar beam orientations for use in conformal dose escalation of prostate radiotherapy. British Journal of Cancer 83(Suppl 1): 74

Kubalakova, M.; Vrana, J.; Cihalikova, J.; Lysak, M.A.; Dolezel, J. 1999: Optimisation of C-PRINS for chromosome identification in barley and wheat. Biologia 54(Suppl 7): 54

Virkutyte, J.; Rokhina, E.; Jegatheesan, V. 2010: Optimisation of electro-Fenton denitrification of a model wastewater using a response surface methodology. Bioresource Technology 101(5): 1440-1446

Schnug, E.; Haneklaus, S.; Fleckenstein, J. 2000: Optimisation of ICP-MS for sulfur and iodine determination in soil and plant materials. Communications in Soil Science and Plant Analysis 31(11-14): 1437-1438, June/July

Alber, M.; Birkner, M.; Laub, W.; Nuesslin, F. 2000: Optimisation of IMRT under biological and practical constraints using Monte Carlo dose computation. Radiotherapy and Oncology 56(Suppl 1): S79

Lobo, A.M.; Adamson, P.; Clark, B.; Lightman, S. 2000: Optimisation of PCR technique for diagnosis of intraocular lymphoma. IOVS Investigative Ophthalmology and Visual Science 41(4): S368

Kustosz, R.; Darlak, M.; Gawlikowski, M.; Korczak, A. 2003: Optimisation of POLHIVAD electrohydraulic converter construction. International Journal of Artificial Organs 26(7): 627

Meinhart,A.D.; Bizzotto,C.S.; Ballus,C.A.; Prado,M.A.; Bruns,R.E.; TeixeiraFilho,J.; Godoy,H.T. 2010: Optimisation of a CE method for caffeine analysis in decaffeinated coffee. Food Chemistry 2010(4): 1155-1161

Bekkering,J.; Broekhuis,A.A.; Gemert,W.J.T.van 2010: Optimisation of a green gas supply chain - a review. Bioresource Technology 1(2): 450-456

Plumb, A.P.; Rowe, R.C.; York, P.; Doherty, C. 2000: Optimisation of a tablet-coating formulation using guided evolutionary simulated annealing. Journal of Pharmacy and Pharmacology 52(Suppl): 186

Ahmed, S.I.; Coulson, J.M.; Woll, P.J. 1999: Optimisation of an RNA extraction method from blood for use in detection of micrometastases by RT-PCR in solid tumours. British Journal of Cancer 80(Suppl 2): 32

Timmel, T.; Goubergrits, L.; Aguilera, D.; Affeld, K. 2003: Optimisation of an artificial heart valve with a purge flow for use in cardiac assist devices. International Journal of Artificial Organs 26(7): 661

Perry, I.; Harrison, R.F.; Bryan, R.T.; Haddadin, W.; Taniere, P.; Shepherd, N.A.; Jankowski, J.A.Z. 2003: Optimisation of an endoscopic biopsy protocol in long segment Barretts oesophagus Evidence from 125 consecutive cases. Gut 52(Suppl 1): A45

Densem, C.G.; Burgess, M.I.; Ray, S.G.; Ward, C. 2000: Optimisation of angiotensin converting enzyme inhibitors in a specialist heart failure clinic. European Heart Journal 21(Abstract Suppl): 465

Buchanan, A.; Thom, G.; Shorrock, C.; Jermutus, L.; Minter, R. 2003: Optimisation of antibody therapeutics by phage and ribosome display. Human Antibodies 12(1-2): 15

Karacabey,E.; Mazza,G. 2010: Optimisation of antioxidant activity of grape cane extracts using response surface methodology. Food Chemistry 9(1): 343-348

Wardhani,D.H.; Vazquez,J.A.; Pandiella,S.S. 2010: Optimisation of antioxidants extraction from soybeans fermented by Aspergillus oryzae. Food Chemistry 8(3): 731-739

Lautraite, S.; Lasserre Bigot, D.; Esdaile, D. 2000: Optimisation of cell-based assays for medium throughput screening of oxidative stress. Toxicology Letters (Shannon) 116(Suppl 1): 104, September 1st

Adams, M.; Navabi, H.; Jasani, B.; Lipetz, C.; Evans, A.; Mason, M. 1999: Optimisation of cervical tumour lysate loading of dendritic cells for development of a versatile and efficient anti-cervical cancer vaccine Use of Caski cells as a model source of cervical cancer derived tumour lysate. European Journal of Cancer 35(Suppl 4): S355

Lambert, A.; Harris, S.D.; Robertson, W.R. 1999: Optimisation of conditions for increased FSH sensitivity and assay of aromatase activity in granulosa-lutein cells. Journal of Endocrinology 160(Suppl ): P200

Bower, K.; Begg, D.J.; Whittington, R.J. 2010: Optimisation of culture of Mycobacterium avium subspecies paratuberculosis from blood samples. Journal of Microbiological Methods 80(1): 93-99

Tura, O.; Barclay, G.; Turner, M.; Davies, J. 2003: Optimisation of cytokines for ex-vivo stem cell manipulation for abrogation of neutropaenia. Experimental Hematology (New York) 31(7 Suppl 1): 206

Madden, R.H.; Moran, L.; Scates, P. 2003: Optimisation of enrichment media and incubation conditions for the recovery of Campylobacter spp from retail packs of raw poultry. IJMM International Journal of Medical Microbiology 293(Suppl 35): 137

Kahveci,D.; GuoZheng; Ozcelik,B.; XuXueBing 2010: Optimisation of enzymatic synthesis of diacylglycerols in binary medium systems containing ionic liquids. Food Chemistry 9(3): 880-885

Mcquat, A.M.; Pritchard, M.; Voice, M.; Friedberg, T.; Wolf, C.R.; Burchell, B. 2000: Optimisation of expression of UDP-glucuronosyltransferases in Escherichia coli. Drug Metabolism Reviews 32(Suppl 1): 81

Fonder,N.; Heens,B.; Xanthoulis,D. 2010: Optimisation of fertilisation for irrigated vegetables. Biotechnologie, Agronomie, Societe Et Environnement: S1, 103-111

Abul Hassan, K.; Boulton, M. 1999: Optimisation of gene transfer to cultured human retinal pigment epithelial cells and uveal melanocytes Investigation of tyrosinase activity and gene expression. Pigment Cell Research (Suppl 7): 40

Paucar-Menacho, L.M.; Berhow, M.A.; Mandarino, J.M.G.; Mejia, E.G.; ChangYoonKil 2010: Optimisation of germination time and temperature on the concentration of bioactive compounds in Brazilian soybean cultivar BRS 133 using response surface methodology. Food Chemistry 9(2): 636-642

Ingram, H.M.; Jacobs, S.P.; Davey, M.R.; Lowe, K.C.; Power, J.B. 1999: Optimisation of gus transgene expression in immature zygotic embryos of wheat using a high osmoticum maltose treatment. Journal of Experimental Botany 50(Suppl ): 20

Brown, J.P.; Happerfield, L.C.; Bobrow, L.G. 2000: Optimisation of heat mediated antigen retrieval solutions for oestrogen, progesterone receptors and MIB1 antibodies. Journal of Pathology 190(Suppl): 50A

Dearnaley, D.P. 2000: Optimisation of high dose treatment for prostate cancer from conformal to IMRT. Radiotherapy and Oncology 56(Suppl 1): S123

Mah, P.M.; Jenkins, R.C.; Rostami Hodjegan, A.; Newell Price, J.; Doane, A.; Ibbotson, V.; Tucker, G.; Ross, R.J. 2002: Optimisation of hydrocortisone replacement therapy. Clinical Science (London) 103(1): 24P

Gremillet, E.; Champailler, A.; Soler, C. 2000: Optimisation of injected activity of 99mTc labeled tracers for myocardial gated SPECT. Journal of Nuclear Medicine 41(5 Suppl): 154P

Kotlyar, E.; Spratt, P.M.; Wilson, M.K.; Arnold, R.H.; Mccaffrey, D.; Keogh, A.M.; Macdonald, P.S. 2000: Optimisation of left ventricular function with carvedilol prior to high risk cardiac surgery. Journal of Heart and Lung Transplantation 19(1): 74

Visser, C.; Harders, L.; Voorwinden, H.; Eloualid, M.; Danhof, M.; De Boer, B.; Van Bloois, L.; Crommelin, D.J.A. 2003: Optimisation of liposomes targeted to the transferrin receptor on the in vitro blood-brain barrier. Journal of Controlled Release 87(1-3): 251, 21 February

Castagnet, J.F.M.risson; Dorent, R.; Dubourg, O.; Gandjbakhch, I.; Jondeau, G. 2002: Optimisation of medical treatment in severe heart failure patients in tertiary care centers Benefit on hospitalisation rate. European Heart Journal 23(Abstract Suppl): 31

Forst, C.V. 1999: Optimisation of molecular function. Koehler, J M, Mejevaia, T, Saluz, H P Biomethods; Microsystem technology: A powerful tool for biomolecular studies 529-574

Poliakov, A.; Johansson, A.; Akerblom, E.; Lindeberg, G.; Hallberg, A.; Danielson, U.H. 2004: Optimisation of peptide-based inhibitors of full-length hepatitis C virus NS3 protease. Antiviral Research 62(2): A51

Sinha, A.; Wetten, A.C.; Caligari, P.D.S. 2004: Optimisation of protoplast production in white lupin. Biologia Plantarum 47(1): 21-25, 2003-

Georges, J.Y.; Guinet, C. 2000: Optimisation of pup growth in subantarctic fur seals on Amsterdam Island. Advances in Ethology 35: 68

Cowen, R.L.; Williams, K.J.; Patterson, A.V.; Robinson, S.K.; Sheppard, F.; Telfer, B.A.; Lian, L.Y.; Stratford, I.J. 2001: Optimisation of reductase enzymes for use in hypoxia regulated gene directed enzyme prodrug therapy. British Journal of Cancer 85(Suppl 1): 14

Diaz Cruz, M.S.; Grabaric, B.S.; Grabaric, Z.; Esteban, M.; Casassas, E. 1999: Optimisation of resolution function in signals ratio method and deconvolution by polynomial division Quantitation of Cd and In from their global signals obtained at carbon fibre disk ultramicroelectrode. Analytica Chimica Acta 382(1-2): 105-115

Sotelino, J.A.; Seif, C.; Braun, P.; Boehler, G.; Bross, S.; Loch, T.; Weichert, K.; Stoeckle, M.; Juenemann, K.P.ter 2000: Optimisation of sacral anterior root stimulation by the application of multichannel-generated quasitrapezoidal pulses in an anodal block stimulation technique. European Urology 37(Suppl 2): 33

Mansfield, R.; Moss, A.; Buonaccorsi, G.; Opanuga, A.; Mcewan, J.; Bown, S. 2000: Optimisation of sensitiser dose in endovascular photodynamic therapy. Clinical Science 99(2): 11P

Wilson, A.M.; Sims, E.J.; Lipworth, B.J. 1999: Optimisation of symptoms and lung function by corticosteroids may not equate with suppression of markers of asthmatic inflammation. Journal of Allergy and Clinical Immunology 103(1 Part 2): S62

Williams, A.P.; Peh, C.A.; Purcell, A.W.; Mccluskey, J.; Elliott, T. 2002: Optimisation of the MHC class I peptide cargo is catalysed by tapasin. Clinical Science (London) 103(1): 27P

Wilson, S.H.; Kennedy, F.P.; Garratt, K.N. 2001: Optimisation of the management of patients with coronary heart disease and type 2 diabetes mellitus. Drugs and Aging 18(5): 325-333

YanMingMing; LiuWei; FuYuJie; ZuYuanGang; ChenCaiYun; LuoMeng 2010: Optimisation of the microwave-assisted extraction process for four main astragalosides in Radix Astragali. Food Chemistry 9(4): 1663-1670

Taubert, K.A.; Dajani, A.S. 2001: Optimisation of the prevention and treatment of bacterial endocarditis. Drugs and Aging 18(6): 415-424

D.G.oot, T.J.; Verheyen, L.; Bex, M.; Detre, K.; Mortelmans, L.; Verbruggen, A.; Bormans, G. 2003: Optimisation of the synthesis, quality control and metabolic analysis of PMP for the in vivo evaluation of cholinesterase activity in humans. Journal of Labelled Compounds and Radiopharmaceuticals 46(Suppl 1): S203

Striedner, G.; Scherrer, V.; Landberg, A.; Duerrschmid, K.; Cserjan Puschmann, M.; Poetschacher, F.; Kern, J.; Bayer, K. 2003: Optimisation of the transcription tuning concept for lactose induction. FEMS Congress of European Microbiologists Abstract Book 1: 243

Piehlmeier, W.; Koenig, A.; Fahn, J.; Renner, R.; Landgraf, R. 2003: Optimisation of the vascular risk profile by implementation of a disease management programme for diabetes mellitus A two year prospective analysis. Diabetologia 46(Suppl 2): A 339

Meinert, C.; Brack, W. 2010: Optimisation of trapping parameters in preparative capillary gas chromatography for the application in effect-directed analysis. Chemosphere 78(4): 416-422

Chien, Y.W.; Lin, S. 2002: Optimisation of treatment by applying programmable rate-controlled drug delivery technology. Clinical Pharmacokinetics 41(15): 1267-1299

D'elia, G.; Ali El Dein, B.; El Mekresh, M.; Thueroff, J.W.; Ghoneim, M.A. 2002: Optimisation of ureteral replacement An experimental study in dogs. European Urology Suppls 1(1): 102

Isaac,P.R.D.; Hayes,C.R.; Akers,R.K. 2010: Optimisation of water and energy use at the Wales National Pool. Water And Environment Journal: 1, 39-48

Salah,R.B.; Chaari,K.; Besbes,S.; Ktari,N.; Blecker,C.; Deroanne,C.; Attia,H. 2010: Optimisation of xanthan gum production by palm date juice by-products using response surface methodology. Food Chemistry 1(2): 627-633

Leong, J.F.W.M.; Brady, J.M.; Mcgee, J.O.d 2002: Optimised greyscale quantisation through principal component analysis as a means of compensating for histochemical stain variation. Analytical Cellular Pathology 24(6): 210

Amiel, S.A.; Ablett, J.; Reid, H.; White, M.; Turner, E.; Blott, M. 2003: Optimised management of diabetic pregnancy reduces fetal loss. Diabetologia 46(Suppl 2): A 256

Bouchalat, Y. 2001: Optimised method for the treatment and energetic upgrading of urban and industrial sludge purifying plants. Official Gazette of the United States Patent and Trademark Office Patents 1242(2)

Liu, B.; Robinson, M.; Han, Z.; Mcgrath, Y.; Branston, R.; Reay, P.; Coffin, R. 2003: Optimised oncolytic herpes simplex virus for cancer treatment. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1149

Rogatsch, H.; Mairinger, T.; Horninger, W.; Gschwendtner, A.; Bartsch, G.; Mikuz, G. 2000: Optimised preembedding method improves histologic yield of prostatic core needle biopsies. European Urology 37(Suppl 2): 73

Tansupo, P.; Suwannasom, P.; Luthria, D.L.; Chanthai, S.; Ruangviriyachai, C. 2010: Optimised separation procedures for the simultaneous assay of three plant hormones in liquid biofertilisers. Phytochemical Analysis: Pca 21(2): 157-162

El Samaligy, M.; El Miligi, M.; El Mahrouk, G.; El Messiry, S.; El Gazayerly, A.; Kader, O. Abdel 1999: Optimised sustained action beclomethasone inhalation delivery system. Journal of Pharmacy and Pharmacology 51(Suppl ): 193

Methner, F.J. 1999: Optimised yeast propogation by means of continuous aeration. Journal of the Institute of Brewing 105(3): 142

Nirmalan, N.; Storey, C.S.; Sims, P.F.G.; Hyde, J.E. 2003: Optimising 2D gel and MALDI-TOF mass spectrometry techniques for the analysis of the Plasmodium falciparum proteome. Experimental Parasitology 105(1): 60

Cox, C.V.; Goulden, N.J.; Oakhill, A.; Pamphilon, D.H.; Blair, A. 2002: Optimising Culture Conditions for the Growth of ALL Progenitor Cells. Blood 100(11): Abstract No. 2992

Ferraro, Mary Jane 1999: Optimising ESBL detection in a routine laboratory. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 16

Kuehlcke, K.; Naundorf, S.; Laufs, S.; Fauser, A.A.; Fruehauf, S. 2002: Optimising Retroviral-Mediated Gene Transfer into Hematopoietic Stem Cells under Clinically Relevant Conditions. Blood 100(11): Abstract No. 5523

Nilsson, H.; Vicencio, M.; Ihse, I.; Stenram, U.; Wadstrom, T. 2002: Optimising a PCR-DGGE assay for Helicobacter species in paraffin embedded pancreatic tissue. Gut 51(Suppl 2): A71

Villegas,B.; Tarrega,A.; Carbonell,I.; Costell,E. 2010: Optimising acceptability of new prebiotic low-fat milk beverages. Food Quality And Preference: 2, 234-242

Head, S.; White, J.; Melvin, D. 2000: Optimising adherence to combination therapies for families with HIV infection. AIDS 14(Suppl 4): S47

Simmons, D.; Kenealy, T. 1999: Optimising ambulatory diabetes care in the information age: primary care, secondary care or integrated care?. New Zealand Medical Journal 112(1080): 1-3

Frampton, C.M.; Warburton, B.; Henderson, R.; Morgan, D.R. 1999: Optimising bait size and 1080 concentration for the control of brushtail possums. Wildlife Research 26(1): 53-59

Wynberg, R.P. 2003: Optimising benefits from the commercialisation of southern African biodiversity. South African Journal of Botany 69(2): 249-250

Scott, I. 1999: Optimising care of the hospitalised elderly. A literature review and suggestions for future research. Australian and New Zealand Journal of Medicine 29(2): 254-264

Sims, E.C.; Powell, M.E.B.; Rothman, M.T.; Warner, T.D. 2000: Optimising coronary artery radiation using targeted radioimmunotherapy. British Journal of Cancer 83(Suppl 1): 33

Cox, C.; Goulden, N.; Pamphilon, D.; Blair, A. 2002: Optimising culture conditions for the growth of clonogenic acute lymphoblastic leukaemia cells. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 92

Barbolosi, D.; Ciccolini, J.; Iliadis, A. 2002: Optimising drug regimens in chemotherapy by an efficacy-toxicity mathematical model. Proceedings of the American Association for Cancer Research Annual Meeting 43: 208

Dalby, P.A. 2003: Optimising enzyme function by directed evolution. Current Opinion in Structural Biology 13(4): 500-505

Karlsen, A.; Steine, T.; Sehested, E. 2003: Optimising genetic gain in a small population. Journal of Dairy Science 86(Suppl 1): 195

Coombes, J.S.; Smith, T.P.; Dilger, J.; Penney, G.; Davoren, B.; Geraghty, D.P. 2001: Optimising high intensity treadmill training using vVO2max and Tmax. Medicine and Science in Sports and Exercise 33(5 Suppl): S131

Bath, P.M. 2000: Optimising homeostasis. British Medical Bulletin 56(2): 422-435

Schafer, D.F.; Sorrell, M.F. 2002: Optimising immunosuppression. Lancet 360(9340): 1114-1115

Jenkins, R.G.; Hart, S.L.; Meng, Q.H.; Kinnon, C.; Laurent, G.J.; Mcanulty, R.J. 2000: Optimising lid vector complex preparation leads to enhanced gene expression in the lung. Thorax 55(Suppl 3): A4

Schostak, M.; Panick, M.; Goessl, C.; Christoph, F.; Staehler, M.; Miller, K. 2001: Optimising local anaesthesia for systematic tenfold prostatic biopsy. European Urology 39(Suppl 5): 181

Stanek, B. 2000: Optimising management of patients with advanced heart failure: the importance of preventing progression. Drugs and Aging 16(2): 87-106

Cullinane, A.B.; Waldock, A.; Khong, C.H.; Diamond, J.P.; Sparrow, J.M. 2000: Optimising measurement parameters which discriminate normal eyes from eyes with primary open angle glaucoma using the TopSS scanning laser ophthalmoscope. IOVS Investigative Ophthalmology and Visual Science 41(4): S91

LiuChengHai; ZhengXianZhe; Shi,J.; XueJun; Lan,Y.B.; JiaShuHua 2010: Optimising microwave vacuum puffing for blue honeysuckle snacks. International Journal Of Food Science and Technology: 3, 506-511

Norton, I.D.; Clain, J.E. 2001: Optimising outcomes in acute pancreatitis. Drugs 61(11): 1581-1591

Sasayama, S. 2004: Optimising outcomes in end-stage heart failure: differences in therapeutic responses between diverse ethnic groups. Drug Safety 27(Suppl 1): 19-24

Shang, A.B.; Gan, T.J. 2003: Optimising postoperative pain management in the ambulatory patient. Drugs 63(9): 855-867

Watkins,M. 2010: Optimising productivity and health in dairy cows. International Dairy Topics: 1, 15-16

Seppenwoolde, Y.; Engelsman, M.; De Jaeger, K.; Muller, S.; Belderbos, J.; Boersma, L.; Lebesque, J. 2000: Optimising radiation treatment plans for lung cancer using functional information. Radiotherapy and Oncology 56(Suppl 1): S58

Maurstad, G.; Muren, L.P.; Hafslund, R.; Anker, G.; Dahl, O. 2000: Optimising tangential breast irradiation with partially wedged beams A one-dimensional intensity-modulation technique. Radiotherapy and Oncology 56(Suppl 1): S139

Perrie, Y.; Gregoriadis, G. 1999: Optimising the cationic lipid content in liposome-mediated DNA immunisation. Journal of Pharmacy and Pharmacology 51(Suppl ): 330

Griffiths, H.D.; Pritchard, L.; Evans, C.; Kaderbhai, M.A.; Kell, D.B.; Winson, M.K. 2003: Optimising the directed evolution process to produce novel protein molecules. FEMS Congress of European Microbiologists Abstract Book 1: 53

Ljutic, D.; Puretic, Z.; Maleta, I.; Ursea, N.; Ion, I.C.; Covic, A.; Mota, E.; Veljancic, Lj; Vankova, S.; Goncalves, L.; De Oliveira, M.; Spudass, A. 2002: Optimising the efficiency of the HD treatment Impact of the dialyser and treatment conditions. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 291

Cockcroft, C.E.; Healy, S.; Den Boer, B.; Murray, J.A.H. 1999: Optimising the growth rate of plants. Plant Biology (Rockville) : 198

Ferrieres, J.; Danchin, N.; Grenier, O.; Thomas, D.; Cantet, C.; Cambou, J.P. 2001: Optimising the prescription of statins after an acute coronary syndrome. European Heart Journal 22(Abstract Suppl): 494

Sam, T. 2003: Optimising the therapeutic trinity of active ingredient, delivery system and functional packaging. Journal of Controlled Release: Official Journal of the Controlled Release Society 87(1-3): 153-157

Fedorov, V.M.; Strakhov, S.N.; Philppov, A.I.; Kostyukova, Z.I.; Mikhailov, A.G.; Redkina, V.Y. 2003: Optimising the treatment of burned patients by usage of Tibetan Healing Techniques. Tulunay, F C, Orme, M European collaboration: Towards drug development and rational drug therapy: 82

Owen, A. 2002: Optimising the use of beta-blockers in older patients with heart failure. Drugs and Aging 19(9): 671-684

Hermann, L.S. 2000: Optimising therapy for insulin-treated type 2 diabetes mellitus. Drugs and Aging 17(4): 283-294

Ngan, S.Y. 2001: Optimising treatment for resectable rectal cancer: is preoperative therapy beneficial?. Drugs and Aging 18(2): 79-85

Croal, B.L.; Ramsay, C.R.; Dickie, A.; Walton, S.; Ross, I.S. 2001: Optimising troponin risk stratification cut-off levels in chest pain patients without ST-segment elevation. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S189

Mulders, P.; Tiemessen, D.; Oosterwijk Wakka, J.; Debruyne, F.; Oosterwijk, E. 2000: Optimising tumour vaccines in renal cell carcinoma. European Urology 37(Suppl 2): 152

Hickey, A.M.; O'doherty, L.J.; Hardiman, O. 2003: Optimism and pessimism in motor neuron disease Comparisons to other neurological populations. European Journal of Neurology 10(Suppl 1): 85

Seghal Kiran, G.; Anto Thomas, T.; Selvin, J.; Sabarathnam, B.; Lipton, A.P. 2010: Optimization and characterization of a new lipopeptide biosurfactant produced by marine Brevibacterium aureum MSA13 in solid state culture. Bioresource Technology 101(7): 2389-2396

Tiemeyer, M.; Hague, C.; Brandley, B.K. 2001: Optimization and comparative analysis of capillary electrophoresis for N-linked oligosaccharides released by N-glycanase. Glycobiology 11(10): 924

Holdsworth, C.; Bai, B.; Leahy, R.; Chatziioannou, A.; Dahlbom, M.; Levin, C.; Mcelroy, D.; Janecek, M.; Hoffman, E. 2001: Optimization and comparison of clinical 3D PET and 2D PET Reconstruction and data correction techniques. Journal of Nuclear Medicine 42(5 Suppl): 199P

Lim, C.K.; Min, D.M.; Byun, H.K.; Kim, J.Y.; Kang, I.S.; Jun, J.H. 2003: Optimization and efficacy of PGD with FISH in 7 years experience. Fertility and Sterility 80(Suppl 3): S194

Wang, S.; Anderson, S.; Clarke, R.; Duncan, K.; Eland, S.; Jackson, W.; Lyon, C.; Mcclue, S.; Meades, C.; Osnowski, A.; Perry, A.; Renachowski, S. 2003: Optimization and evaluation of substituted 2-phenylamino-4- -pyrimidine CDK inhibitors as oral anti-cancer drug candidates. Proceedings of the American Association for Cancer Research Annual Meeting 44: 792

Pandian, S.RamKumar.; Deepak, V.; Kalishwaralal, K.; Rameshkumar, N.; Jeyaraj, M.; Gurunathan, S. 2010: Optimization and fed-batch production of PHB utilizing dairy waste and sea water as nutrient sources by Bacillus megaterium SRKP-3. Bioresource Technology 101(2): 705-711

Silva, J.R.; Silva, L.T.; Druzian, J.I. 2010: Optimization and intralaboratorial validation of method for analysis of chloramphenicol residues in goat milk by GC/ECD. Quimica: 1, 90-96

Behrens, H.L.; Taylor, A.M.; Tu, C.H.; Cribbs, D.H.; Cotman, C.W.; Jeon, N.L. 2003: Optimization and polarity of neurons in microfabricated culture chamber for neuroscience research. FASEB Journal 17(4-5): Abstract 164

Louis, S.A.; Clarke, E.; Thomas, T.E.; Sutherland, H.J. 1999: Optimization and scale-up of negative selection for purging myeloma cells from patients marrow and/or leukapheresis blood. Blood 94(10 Suppl 1 Pt 2): 352b-353b

Kelly, W.J.; Clemson, M.; Fredette, J. 2002: Optimization and scale-up of the alkaline lysis step. Abstracts of Papers American Chemical Society 224(1-2): BIOT 144

Castaldi, M.J.; Jones, B.P.; Ragan, J.A.; Murry, J.; Li, B.; White, T.D.; Sitter, B.J.; Mcdermott, R.E. 2001: Optimization and scale-up of the synthesis of 4-oxo-5,6,7,8-tetrahydro-4H-cyclohepta furan-3-carboxylic acid. Abstracts of Papers American Chemical Society 221(1-2): ORGN 525

Liu, S.; Berlin, K.D.; Simms Kelley, M.D.; Nelson, E.C.; Benbrook, D.M. 1999: Optimization and synthesis of -4- -1-propenylbenzoic acid-11-. Journal of Labelled Compounds and Radiopharmaceuticals 42(8): 789-796

IIda, H.; Shidahara, M.; Watabe, H.; Kitamura, K.; Kim, K.M.; Hachiya, T. 2000: Optimization and validation for quantitative brain perfusion imaging using 99mTc Ethyle Cycteinate Dimmer and SPECT. Journal of Nuclear Medicine 41(5 Suppl): 185P

O'grady, A.B.; Dumur, C.I.; Powers, C.N.; Mas, V.R.; Garrett, C.T.; Ferreira Gonzalez, A. 2002: Optimization and validation of a real-time PCR assay for t quantification in lymphoma specimens. Laboratory Investigation 82(1): 257A

Gierthy, J.F.; Arcaro, K.F.; Li, A.; Silber, P.; Lloyd, S.; Yang, Y. 2003: Optimization and validation of the MCF-7 focus assay for estrogen modulators. Toxicological Sciences 72(S-1): 154-155

Padmavathi, L.; Padmasree, K.; Raghavendra, A.S. 2001: Optimization by mitochondrial oxidative metabolism of photosynthetic carbon assimilation. Photosynthesis Research 69(1-3): 217

Wong, S.H.; Bjerke, J.; Schur, B.C.; Wagner, M.A.; Chang, J.; Bratanow, N. 2001: Optimization for genotyping CYP2D6 by conventional and real-time PCR. Clinical Chemistry 47(S6): A77

Ma, S.K.Y.; Siwoski, A.; Bainbridge, T.C.; Woolcock, B.; Lam, W.L.; Vielkind, J.R. 2001: Optimization for integrity and yield of DNA extraction from laser capture microdissected cells from archival biopsies. Proceedings of the American Association for Cancer Research Annual Meeting 42: 532

MengFanYun; LiuXiaoNan; JiaLe; SongZhen; DengPeng; FanKeMing 2010: Optimization for the production of exopolysaccharides from Morchella esculenta SO-02 in submerged culture and its antioxidant activities in vitro. Carbohydrate Polymers: 3, 700-704

Leon, V.J.; Gutierrez, N.C.; Garcia, J.L.; San Miguel, J.F. 2001: Optimization for the thermocycler times applied to HLA typing by SSP. European Journal of Immunogenetics 28(2): 361

Snieckus, V. 1999: Optimization in organic synthesis. Medicinal Research Reviews 19(5): 342-347

Sukhovol'skii, V.G.; Fomina, I.R.; Bil', K.Y.; Nishio, J.N.; Khlebopros, R.S. 2002: Optimization model of photosynthetic leaf Model of optimal photosynthetic CO2 fixation across leaves of mesophytic C3 plants. Doklady Akademii Nauk 382(2): 283-285

Pantoflickova, D.; Blum, A.L.; Delarive, J.; Blackmon, K.; Dorta, G. 1999: Optimization of 13C urea breath test for diagnosis of H pylori infection. Gastroenterology 116(4 Part 2): A276

ArashRafat; MaheranAbdAziz; AzmiAbdRashid; SitiNor,A.A.; HosseinKamaladini; Sirchi,M.H.T.; Javadi,M.B. 2010: Optimization of Agrobacterium tumefaciens-mediated transformation and shoot regeneration after co-cultivation of cabbage cv KY Cross with AtHSP101 gene. Scientia Horticulturae 4(1): 1-8

Dedecker, Andy P.; Goethals, Peter L.M.; Gabriels, Wim; De Pauw, Niels 2004: Optimization of Artificial Neural Network model design for prediction of macroinvertebrates in the Zwalm river basin. Ecological Modelling 174(1-2): 161-173

Huber, R.; Seidl, C.; Schmid, E.; Becker, K.F.; Schuhmacher, C.; Apostodidis, C.; Nikula, T.; Schwaiger, M.; Senekowitsch Schmidtke, R. 2003: Optimization of Bi-213-immunotherapy in intraperitoneal cell dissemination. Journal of Nuclear Medicine 44(5 Suppl): 178P

Sniecinski, I.; Nowicki, B.; Kay, C. 1999: Optimization of CD34 positive cell collection. Transfusion 39(10 Suppl): 6S

Schmitt, M.; Gribba, M.; Limacher, J.M.; Olschwang, S.; Mandel, J.L. 2002: Optimization of DHPLC experimental conditions for mutation analysis of the hereditary non polyposis colon cancer genes hMLH1 and hMSH2. European Journal of Human Genetics 10(Suppl 1): 87-88

Lenigk, R.; Liu, R.H.; Rhine, D.; Singhal, P.; Athavale, M.; Chen, Z.; Grodzinski, P. 2002: Optimization of DNA hybridization kinetics in microfluidic channels using electronic on-line detection. Abstracts of Papers American Chemical Society 224(1-2): BIOT 27

Guo, Z.; Jensen, R.V.; Boches, S.K.; Gullans, S.R.; Rheinwald, J.G. 2003: Optimization of DNA microarray hybridization methods to detect cancer-related changes in gene expression in cultured human keratinocytes. Journal of Investigative Dermatology 121(1): 0132

Kelly, J.J.; Sappelsa, L.; Bavykin, S.G.; Mirzabekov, A.D.; Stahl, D.A. 1999: Optimization of DNA microarrays for the rapid characterization of microbial community population structure. Abstracts of the General Meeting of the American Society for Microbiology 99: 470-471

Koechling, J.; Bahrami, M.; Stripecke, R.; Wittig, B.; Henze, G.; Seeger, K.; Schmidt, M. 2003: Optimization of DNA vaccine strategies protects mice against syngeneic Ph+ ALL. Blood 102(11): 746a

Baker, C.H.; Solorzano, C.C.; Tsan, R.; Killion, J.J.; Fidler, I.J. 2001: Optimization of EGF-R signalling blockage for therapy of human pancreatic carcinoma implanted orthotopically in nude mice. Proceedings of the American Association for Cancer Research Annual Meeting 42: 788

TongHaiShen; SongLin; ZhangZhiGang; ZhaoZhiZhong; SongXiYun; LiQiaoYun 2010: Optimization of EST-SSR system on heading Chinese cabbage and primer screening. Science and Technology Review: 3, 76-81

Shadduck, R.K.; Zeigler, Z.R.; Raymond, J.M.; Gryn, J.F.; Lister, J. 2000: Optimization of G-CSF induced peripheral blood stem cell collection. Acta Haematologica (Basel) 103(Suppl 1): 28

Leboulleux, S.; Cabrol, S.; Perin, L.; Le Bouc, Y. 1999: Optimization of GH dose in prepubertal growth hormone deficient. Hormone Research 51(Suppl 2): 50

Ferris, M.C.; Shepard, D.M. 2001: Optimization of Gamma Knife radiosurgery. AAAS Annual Meeting and Science Innovation Exposition 167: A40, February 15-20

Vega, C.V.; Good, T.; Kazantzis, N. 2002: Optimization of HIV antiretroviral therapy. Abstracts of Papers American Chemical Society 224(1-2): BIOT 22

Duarte, C.G.; Polizello, A.C.; Assis-Pandochi, A.I.; Spadaro, A.C. 2000: Optimization of HPLC analysis for the determination of propylthiouracil levels in plasma and serum. Journal of Pharmaceutical and Biomedical Analysis 23(1): 237-241

Wakte,K.V.; Thengane,R.J.; NarendraJawali; Nadaf,A.B. 2010: Optimization of HS-SPME conditions for quantification of 2-acetyl-1-pyrroline and study of other volatiles in Pandanus amaryllifolius Roxb. Food Chemistry 1(2): 595-600

Chen, Q.; Larsson, L.; Jones, A.D.niel 2003: Optimization of LC/LC/MS for mapping of aging-related posttranslational modifications of large proteins and protein complexes. Abstracts of Papers American Chemical Society 226(1-2): ANYL 65

Lutzko, C.; Yu, X.; Kohn, D.B. 2002: Optimization of Lentiviral Gene Transfer to Human Embryonic Stem Cells. Blood 100(11): Abstract No. 825

Henry, D.R.; Durant, J.L. 2002: Optimization of MDL substructure search keys for the prediction of activity and toxicity. Abstracts of Papers American Chemical Society 224(1-2): COMP 256

Tan, P.; Kropshofer, H.; Mandelboim, O.; Bulbuc, N.; Hammerling, G.J.; Momburg, F. 2002: Optimization of MHC class I-bound peptides requires tapasin-mediated interaction with TAP. Tissue Antigens 59(2 Suppl): 5

Buffo, R.A.; Reineccius, G.A. 2001: Optimization of MS parameters for breath analysis. Abstracts of Papers American Chemical Society 222(1-2): AGFD149

Lawrence, R.M.; Biller, S.A.; Chen, Y.; Dickson, J.K.Jr.; Fryszman, O.M.; Poss, M.A.; Connolly, F.; Harrity, T.W.; Jolibois, K.G.; Kunselman, L.K. 1999: Optimization of MTP inhibitors by solution and solid phase parallel array synthesis. Abstracts of Papers American Chemical Society 217(1-2): ORGN 334

Leon, V.J.; Leon, A.J. 2003: Optimization of PCR-SSP conditions applied to HLA class I typing. Genes and Immunity 4(Suppl 1): S66

Leon, V.J.; Gutierrez, N.C. 2001: Optimization of PCR-SSP conditions applied to HLA typing by SSP. Human Immunology 62(Suppl 1): S154

Leon, V.J.; Gonzalez, C. 2002: Optimization of PCR-SSP conditions applied to low and high resolution HLA typing by SSP. European Journal of Immunogenetics 29(2): 176

Leon, V.J.; Gonzalez Buitrago, J.M. 2003: Optimization of PCR-SSP conditions for HLA genotyping for small samples of DNA. Genes and Immunity 4(Suppl 1): S65

Leon, V.J.; San Miguel, J.F. 2001: Optimization of PCR-SSP conditions for typing of HLA class I and II with small samples of DNA. Human Immunology 62(Suppl 1): S155

Leon, V.J.; Gonzalez Buitrago, J.M.nuel 2002: Optimization of PCR-SSP for genotyping of HLA class II with small samples. Human Immunology 63(Suppl 1): S88

Leon, V.J.; Leon, A.J.; Cuesta, S. 2003: Optimization of PCR-SSP times applied to HLA typing. Human Immunology 64(Suppl 1): S83

Sodee, D.B.; Malguria, N.; Nelson, A.D.; Faulhaber, P.F.; Ellis, R.J.; Devlin, P.R. 2000: Optimization of Prosta Scint sensitivity in the diagnosis and staging of prostate cancer. Journal of Nuclear Medicine 41(5 Suppl): 116P

Wang,X.F.; Zheng,W.H.; Zheng,H.X.; Xie,Q.Q.; Zheng,H.Y.; Tang,H.; Tao,Y.L. 2010: Optimization of RAPD-PCR reaction system for genetic relationships analysis of 15 camellia cultivars. African Journal Of Biotechnology: 6, 798-804

Kong, W.; Nakatsu, C.H. 2010: Optimization of RNA extraction for PCR quantification of aromatic compound degradation genes. Applied and Environmental Microbiology 76(4): 1282-1284

Chiklis, G.R.; Misialek, M.J.; Sadasivan, S.; Astrow, S. 2003: Optimization of RNA extraction from breast cancer tissues. Proceedings of the American Association for Cancer Research Annual Meeting 44: 636

Medeiros, M.; Yamaji, K.; Li, B.; Munoz, R.; Sharma, V.; Suthanthiran, M. 2001: Optimization of RNA yield for mRNA profiling in urinary cells using RNA later. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 733A

Stone, J.L.; Ogdie, M.N.; Kustanovich, V.; Crawford, L.; Kimura, J.; Nelson, S. 2001: Optimization of SBE-TAGS technology for the rapid and cost-effective genotyping of single nucleotide polymorphisms in ADHD. American Journal of Human Genetics 69(4 Suppl): 468

Leon, V.J.; Gutierrez, N.C.; Garcia, J.L.; San Miguel, J.F. 2000: Optimization of SSP method for typing of HLA class I and II with small samples of DNA. Human Immunology 61(Suppl 1): S103

Domski, G.J.; Wanke, R.A. 2002: Optimization of Solid-Phase microextraction techniques for analyzing MTBE. Transactions of the Illinois State Academy of Science 95(Suppl): 63

Saadatnia,G.; HajGhani,H.; Khoo,B.Y.; Maimunah,A.; Rahmah,N. 2010: Optimization of Toxoplasma gondii cultivation in VERO cell line. Tropical Biomedicine: 1, 125-130

Astori, G.; Malangone, W.; Risso, A.; Bigi, L.; Sala, P.; Biffoni, F.; Del Frate, G.; Pipan, C.; Degrassi, A. 2002: Optimization of UCB ex-vivo expansion conditions. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 58